ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
 
 
 
 
 
 

Editorial Board

Tomoaki Tanaka

Editor-in-Chief
Tomoaki Tanaka
Associate Professor
Department of Urology
Osaka City University Graduate School of Medicine
Japan

Biography :

Dr Tomoaki Tanaka started his career as an Assistant professor soon after his post-doctoral research in university of texas, houston and department of cardiology, and is now working as an associate professor since 2006 in department of urology, osaka city university graduate school of medicine. He has been awarded as osaka city mayor in osaka city medical association on 1997 and 2015.

 Biography
Research Interest :

Urology, Endourology, Clinical Oncology, Molecular Biology

 Research Interest
 Network
 Acceptance Letter
Kurt S Zaenker

Editor-in-Chief
Kurt S Zaenker
University Professor
Department of Immunology/Biochemistry/Oncology
Witten-Herdecke University
Germany

Biography :

Kurt S Zaenker was started in 1967 at the Free University Berlin, Berlin by studying human and veterinary medicine. These studies were finished in the late 70 at the University of Munich with doctorates (Ph.D. thesis) in both disciplines. During the postgraduate education, several terms for research were spent at Cambridge (England), Memorial Sloan-Kettering Cancer Center (New York) and the M.D. Anderson Hospital and Cancer Center (Houston).From 1973 to 1975, and was awarded for a Max-Planck-Fellowship for 3 years to continue the eduction in Biochemistry at the Max-Planck-Institute of Biochemistry, Martinsried/Munich.From 1976 to 1982 I was a senior scientist at the Institute of Experimental Surgery, Technical University Munich.From 1982 to 1986. He worked as a senior physician at the tumor out-patients department of the surgical clinic, Technical University Munich. In 1986, he was appointed as Professor for the Chair of Immunology and Oncology at the University Witten/Herdecke, which is the only private university in Germany. Most of the funding of the Institute is done by writing research proposals. The quality of the research has allowed him to continue this funding now for almost 24 years.

 Biography
Research Interest :

Basic and translational research concerning cell-cell communication/interaction, signal transduction and gene activation/silencing with special reference to lymphocyte tumor cell interactions and, from the molecular point of view, to the migration machinery of these cells as well as of fusion of premalignant tumorcells with soma/immunocompetent cells/stem cells.

 Research Interest
 Network
Xiangchun Wang

Editor-in-Chief
Xiangchun Wang
Analytical Scientist
NIAID/NIH
USA

Biography :

Dr. Xiangchun Wang is an Analytical Scientist from NIAID/NIH. He with his eminent personality have published more than 100 articles. He is been as an editor for most prestigious journals and made his remark in science with his best research findings. His eminence in writing an article have fetched no. of scientists, learners and professionals a great platform for their research and was so helpful in citing most no. of items he delivered towards science.

 Biography
Research Interest :

Physical Chemistry, Nanotechnology, Neuroscience, Cancer Research, Analytical Chemistry

 Research Interest
 Network
Jimmy Thomas Efird

Senior Executive Editor
Jimmy Thomas Efird,
PhD
Associate Professor
Departments of Public Health and Cardiovascular Sciences
East Carolina University
USA
Tel. 650-248-8282
Read Interview session with Jimmy Thomas Efird

Biography :

Jimmy Thomas Efird completed his Doctorate in Epidemiology (Biostatistics Concentration) at Stanford University School of Medicine.  Currently he is working as an Associate Professor at the Brody School of Medicine, East Carolina University (ECU) and has a joint appointment as Epidemiologist/Chief Statistician in the Center for Health Disparities Research.  Prior to joining ECU, Dr. Efird was Director of the Biostatistics Facility at the John A. Burns School of Medicine (Honolulu, Hawaii) and an Associate Member of the Cancer Research Center of Hawaii. 

 Biography
Research Interest :

Genetic epidemiology, cancer informatics, brain tumours, soft-tissue sarcomas, and HPV-related cancers.  Additionally, he is founding co-chair for the Advances in Bioinformatics and Genomics Symposium series.  Dr. Efird has over 100 publications in scientific journals and proceedings.

 Research Interest
 Network
William E Grizzle

Executive Editor
William E Grizzle,
MD, PhD
Professor
Department of Pathology
University of Alabama
USA
Tel. 205-934-4214

Biography :

William E Grizzle is a board certified anatomic and clinical pathologist. He has been Principal Investigator of the Southern Division of the Cooperative Human Tissue Network since 1987 and Director of the Tissue Resource Facility at the University of Alabama at Birmingham since 1983. He is internationally recognized as one of the leading authorities in human tissue resources and has published extensively in this area. He is on the Board of Directors and is a founding member of the International Society for Biological and Environmental Repositories. Dr. Grizzle is an internationally recognized researcher with expertise in oral neoplasia. He was Associate Director of the UAB Oral Cancer Research Center (1996-2002). He is Head of the Program for Translational Research in Neoplasia, Department of Pathology, UAB, and Principal Investigator of one of the 3 Validation Laboratories of the Early Detection Research Network.

 Biography
Research Interest :

The early detection of epithelial neoplasias and on biomarkers associated with prognosis.

 Research Interest
 Network
Peter E Barker

Executive Editor
Peter E Barker,
PhD
Division of Biomedical Sciences
National Institute of Standards and Technology
USA
Tel. 301-975-5402/8278

Biography :

Peter E Barker is a Project Leader/Biologist at Biochemical Science Division, National Institute of Standards and Technology (NIST), holds degrees from Cornell (B. A. Biological Sciences) and the University of Texas Graduate School of Biomedical Sciences (M.S./Ph.D., cell and molecular biology, M. D. Anderson Cancer Center, Houston). Following postdoctoral work in biology and human genetics at Yale (New Haven), he served on faculty at UAB (Assistant Professor of Biochemistry and Medical Genetics). After sabbatical work in molecular cytogenetics at DKFZ, Heidelberg (German Cancer Research Center), he was Staff Scientist at Cold Spring Harbor Laboratory prior to moving to NIST in 1997, and initiated the NIST/EDRN-NCI Cancer Biomarkers Reference Laboratory as Principal Investigator in 2000. Work in his lab on qdot imaging was covered on CNN (2004) and designated best paper at the 25th Army Science Conference (2006). He was a member of the NCCLS guidance committee on FISH in medical genetics. Current work is funded by the National Cancer Institute Early Detection Research Network (EDRN), NIH and NIST. He serves on editorial boards of Disease Markers, Clinical Proteomics and Biomarker Insights and has served on biotechnology study sections at NIH, NCI and NSF as reviewer and chairman, and FDA panelist. He is co-chair of the AACR-FDA-NCI Cancer Biomarker Collaborative (CBC), and a member of caHUB/NCI Working Group (2009).

 Biography
Research Interest :

Cancer biomarker validation, high-throughput genetic screening technologies, cellular bioimaging with semiconductor nanocrystals, and mtDNA/NUMTs bioimaging. With NIST and NIH funding, he is currently developing a national standard for HER2 testing in breast cancer. His work includes 91 peer-reviewed publications, and 86 published abstracts in human genetics, biotechnology and cancer biomarker validation.

 Research Interest
 Network
Mong-Hong Lee

Executive Editor
Mong-Hong Lee,
PhD
Professor
Department of Molecular and Cellular Oncology
University of Texas
USA
Tel. 713-794-1323

Biography :

Mong-Hong Lee is currently Professor in the Department of Molecular and Cellular Oncology of University of Texas MD Anderson Cancer Center and a faculty member at The University of Texas Graduate School of Biomedical Sciences at Houston (GSBS). In 1993, Dr. Lee received his Ph.D. degree in Molecular, Cellular, and Developmental Biology from the University of Pittsburgh, where he received the Stanton C. Crawford Award for teaching excellence. He then went on to complete a postdoctoral fellowship while serving as a research associate at Howard Hughes Medical Institute and Memorial Sloan-Kettering Cancer Center (1993-1997).  After completing his fellowship, Dr. Lee came to M. D. Anderson in 1997 as an Assistant Professor (tenure track). He was promoted to his current position of Professor (tenured) in 2010. During his time at M. D. Anderson, Dr. Lee has been the principal investigator or a co-principal investigator for nine funded research projects. He also has been a grant reviewer for several funding agencies. Dr. Lee has been honored for his research activities, led by the Susan G. Komen Breast Cancer Foundation Research Award (2001), Fleming and Davenport Research Award (2001), and William G. McGowan Foundation Research Award (1998). In addition to research, for more than a decade, Dr. Lee has been a key contributor to the education of trainees at M. D. Anderson and the GSBS in a variety of ways. For example, at the GSBS, he has been the course coordinator for the Molecular Genetics of Human Cancer seminar since 2006 and an instructor for the Cancer Cell Signaling course since 2000. Dr. Lee has had a wealth of direct interaction with trainees throughout his career. Specifically, he has directly supervised 40 graduate students, 12 clinical residents and fellows, 12 undergraduate and Allied Health students, 9 postdoctoral research fellows, and 1 medical student. Furthermore, he has chaired or served on 71 examining committees, 67 advisory committees, and 39 supervisory committees. UT M. D. Anderson Cancer Center and the UT GSBS at Houston have well recognized Dr. Lee’s educational efforts. In 2009, he received the John P. McGovern Outstanding Teaching Award, which is given annually to a faculty member at M. D. Anderson and/or the GSBS. Most recently, he has recently been named the February 2010 Faculty Educator of the Month at MD Anderson Cancer Center. Also, he received the M. D. Anderson Outstanding Educator Award in 2003. Currently, Dr. Lee is an ad hoc reviewer for 25 journals. He also has been a guest editor for the journal Breast Diseases. Over the course of his career, Dr. Lee has authored more than 50 articles published in peer-reviewed journals, 4 book chapters, and 3 invited articles.

 Biography
Research Interest :

Characterizing the roles of Cdk inhibitors (CKIs) in cancer formation, and exploiting signaling regulation in cancer therapy. Research projects focusing on: 1) roles of two CKI molecules that he cloned in tumorigenesis; 2) COP9 signalosome signaling regulation; 3) investigating the impact of hypoxia and PIm1 kinase in drug resistance; 4) employing Aurora B kinase inhibitor for cancer therapy; 5) p53-MDM2 signaling regulation and DNA damage; 6) Myc ubiquitination regulation; 7) Glycolysis and cancer metabolism.

 Research Interest
 Network
Ajay Rana

Senior Editor
Ajay Rana,
PhD
Professor
Department of Molecular Pharmacology and Therapeutics
Loyola University
USA

Biography :

Ajay Rana is Professor in the Department of Molecular Pharmacology and Therapeutics. He completed his education at Indian Institute of Chemical Biology, Jadavpur University, Calcutta, India.

 Biography
Research Interest :

Role of MAP kinases and phosphatases in cell growth, migration, metastasis, and cell death and survival pathways.

 Research Interest
 Network
Kenneth Maiese

Senior Editor
Kenneth Maiese,
MD
Professor and Chair
Department of Neurology 
Wayne State University
USA

Biography :

Kenneth Maiese is Professor of Neurology and Neurophysiology of the University of Medicine & Dentistry of New Jersey. He has been serves as an editor-in-cheif, associate editor and editorial board member of 40 reputed journals.

 Biography
Research Interest :

Cancer metabolic disorders, Cerebrovasculature ischemia and related diseases, central nervous system degenerative diseases.

 Research Interest
 Network
Vincent L Wilson

Senior Editor
Vincent L Wilson,
PhD
Professor
Environmental Sciences
Louisiana State University
USA
Tel. 225-578-1753
Read Interview session with Vincent L Wilson

Biography :

Vincent Wilson is Professor of Toxicology in the Department of Environmental Sciences, School of the Coast & Environment at Louisiana State University, Baton Rouge, Louisiana. He received his PhD in Pharmacology & Toxicology from Oregon State University in 1980 and proceeded to postdoctoral studies in molecular genetics under the direction of Dr. Peter A. Jones at the University of Southern California Comprehensive Cancer Center.  With a focus on chemical carcinogenesis, Vincent then spent five years at the National Cancer Institute, NIH, Bethesda, MD, in the Laboratory for Human Carcinogenesis, under the direction of Dr. Curt Harris.  The attraction of an offer to build, develop and run a laboratory for DNA diagnostics for clinical genetics and oncology services drew him out of NCI to The Children’s Hospital, Denver, CO, and the Department of Pathology, University of Colorado Health Sciences Center for six years before accepting a faculty position at the Louisiana State University in 1994.  He served as Chair, Interdepartmental Program in Toxicology at LSU for eleven years.

 Biography
Research Interest :

1) Mechanisms in mutagenesis and carcinogenesis; 2) Determination of the importance of changes in DNA 5-methyldeoxycytidine and chromatin modification patterns to the physiologic and perturbed processes of embryogenesis, differentiation, aging, carcinogenesis, and epigenetic instability; 3) Genetic processes involved in aging, mutagenesis and carcinogenesis; 4) Single base instability, hypermutable phenotypes and oncogenic mutation frequencies; 5) Genotoxic markers of diagnostic value for environmental and human biomonitoring; 6) Genetic markers of diagnostic and prognostic value.

 Research Interest
 Network
Hari K Koul

Senior Editor
Hari K Koul,
PhD
Professor and Director
Department of Surgery
University of Colorado
USA
Tel. 303-724-6300

Biography :

Hari K. Koul is Professor and Director of Research, Division of Urology and Department of Surgery at the University Of Colorado School Of Medicine, Denver, Colorado, USA. He is founding program Director for Urosciences Program and a member of the University of Colorado Cancer Center. He is an internationally recognized researcher in Urology.

 Biography
Research Interest :

Pathophysiology of kidney stone disease, prostate cancer, bladder hypertrophy, urogenital development, and erectile dysfunction.The structure and function of MAP kinase signal transduction pathways in oxalate induced nephrotoxicity as well as the characterization of MAP kinase signal transduction pathways that are critical determinants in the patho-physiologies of bladder hypertrophy, benign prostatic hyperplasia and prostate cancer.

 Research Interest
 Network
Vicente Notario

Senior Editor
Vicente Notario,
PhD
Professor
Radiation Medicine
Georgetown University
USA
Tel. 202-687-2102

Biography :

Vicente Notario graduated with a B.Sc. degree from the University of Salamanca, Spain, in 1974, and received his Ph.D. in Biology from the same institution in 1977. After completing post-doctoral training in the Department of Biochemistry of the University of Cambridge, England, and the U.S. National Cancer Institute, he joined the Department of Biochemistry at the Georgetown University Medical Center (G.U.M.C.) as a Research Assistant Professor, in 1986. Currently, Dr. Notario is Professor in the Departments of Radiation Medicine and of Biochemistry and Molecular & Cellular Biology. He is also Director of the Division of Radiation Research in the Department of Radiation Medicine. Dr. Notario has been Leader of the Radiation Biology & DNA Repair Program and the Molecular Targets & Therapeutic Resistance Program of the Lombardi Comprehensive Cancer Center, at the G.U.M.C. For over twenty years. His laboratory has focused on understanding molecular and cellular mechanisms of cancer initiation and progression as well as those involved in the acquisition of resistance to anti-cancer therapy, with emphasis on pathways that may be exploited to improve the treatment of metastatic cancers and to sensitize human tumors to chemotherapeutic drugs and radiation therapies. Dr. Notario has authored more than 135 publications. The quality and clinical significance of Dr. Notario’s contributions have been recognized and, consequently, continuously funded by the U.S. National Cancer Institute since 1986. Dr. Notario has also received international recognition in the form of numerous invitations to speak at specialized meetings and to become a member of the Editorial Boards of journals such as Cancer Research, The International Journal of Oncology, Current Cancer Therapy Reviews, The Open Cancer Journal, The Journal of Cell Death, The World Journal of Clinical Oncology, and others. Dr. Notario’s expertise in Experimental Molecular Carcinogenesis has been recognized also through invitations to participate in U.S. and international scientific review and advisory committees, such as those for the U.S. National Institutes of Health, the American Association for Cancer Research, the U.S. Department of Defense, the Israel Science Foundation, the Italian National Center for Rare Diseases, the Italian Association for Research on Cancer, and the Department of Education and Science of Spain. In addition, Dr. Notario has been invited to act as an ad hoc expert reviewer for over 50 specialized U.S. national and international scientific journals. His service to Georgetown University included terms in the G.U.M.C. Research Committee and various faculty search committees, the Medical School Admissions Committee and the Lombardi Comprehensive Cancer Center Executive Committee, and is currently serving as Chairman of the Georgetown Institutional Biosafety Committee.

 Biography
Research Interest :

Biochemistry, Molecular Biology, Radiation Biology, Molecular Carcinogenesis and Tumor Biology.

 Research Interest
 Network
Min Li

Senior Editor
Min Li,
PhD
Associate Professor
Department of Neurosurgery
The University of Texas Health Science Center
USA

Biography :

Min Li got his PhD from Emory University at Atlanta, Georgia in 2002. Under the supervision of Dr. Richard W. Compans, a world renowned virologist and immunologist, Dr. Li studied the regulation of a retrovirus envelope protein induced membrane fusion and the association with lipid rafts. He then moved on to Baylor College of Medicine at Houston, Texas, and started his career in cancer research as an Assistant Professor in 2004. Dr. Li joined the University of Texas Health Science Center at Houston, Medical School in 2010 as the Director of Cancer Research Program.

 Biography
Research Interest :

Pancreatic cancer and brain tumor pathogenesis, translational research, new therapies (shRNA therapy, small molecule therapy, and nutrition/diet therapy), and tumor vaccine development. Due to the difficulty in diagnosing pancreatic adenocarcinoma and glioma, and its high resistance to conventional chemotherapy and radiotherapy, new diagnostic and therapeutic strategies are urgently needed for these malignant disease. Dr. Li′s group is the first one to identify a zinc transporter (ZIP4) as a new molecular target in pancreatic cancer, and has developed a novel therapy to treat this malignancy.

 Research Interest
 Network
Samir A Farghaly

Senior Editor
Samir A Farghaly, MD, PhD
Obstetrics and Gynecology
Cornell University
USA
Read Interview session with Samir A Farghaly

Biography :

Samir A Farghaly is a Physician/Scientist,  and faculty member of the Medical College of Cornell University and The New York Presbyterian Hospital /Cornell University Medical Center, New York, NY, USA. He received his M.D Degree from University College London University (1985), and his PhD Degree in molecular biology from London university (1993). He received several clinical and research awards. He has been an invited speaker in several national and international conferences on cancer. He is a member of several national and international societies, organization and foundation of cancer and women health . He is an editor, member of editorial boards and reviewers of several medical journals of Oncology, Gynecology and Gynecological Cancers. He has published 74 articles. He is an editor of a book on ovarian cancer.

 Biography
Research Interest :

Bio markers profile, and screening for ovarian cancer. Mutant BRCA1 and BRCA2 genes profiles in ovarian cancer. Proteomic profiling of metastatic genes of ovarian cancer. Targeted molecular therapy for advanced epithelial ovarian cancer. Minimally invasive surgery for gynecological cancer.

 Research Interest
 Network
Masayoshi Yamaguchi

Masayoshi Yamaguchi
Department of Hematology and Biomedical Oncology
School of Medicine
Emory University
USA
Tel. 404-664-7422

Biography :

Masayoshi Yamaguchi, Ph.D., IOM, FAOE, DDG, DG, is Adjunct Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA (2013-); Visiting Professor in Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX, USA (2012–2013); Visiting Professor in Department of Pathobiology, College of Veterinary Medicine, The University of Missouri-Columbia, MO, USA (2012); Visiting Professor in Department of Foods and Nutrition, The University of Georgia, GA, USA (2011 – 2012); Visiting Professor in Division of Endocrinology and Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, GA, USA (2007 – 2011); Professor in Laboratory of Endocrinology and Molecular Metabolism, Graduate School of Nutritional Sciences, University of Shizuoka, Japan (1993 ~ August 2007); Associate Professor in Graduate School of Nutritional Sciences, University of Shizuoka, Japan (1991~1993); Assistant Professor in School of Pharmaceutical Sciences, University of Shizuoka, Japan (1987~1991); Visiting Assistant Professor in The University of Texas Medical School at Huston, USA (1988); Assistant Professor in Shizuoka College of Pharmacy, Japan (1986~1987); Visiting Assistant Professor in Texas Tech University School of Medicine, USA (1985); Visiting Lecturer in The University of Pennsylvania School of Medicine, USA (1981); Research Associate in Shizuoka College of Pharmacy, Japan (1973 ~ 1986). He received a Ph.D. in Pharmaceutical Sciences from Shizuoka College of Pharmacy (1976, Japan). He has completed his B.S. in Pharmaceutical Sciences, Shizuoka, Japan (1971). Dr. Yamaguchi is engaged in the fields of bone and calcium endocrinology and cell calcium signaling since 1971, and these researches are developed in the aspect of biochemistry, molecular biology, endocrinology, metabolism, nutrition, pharmacology, and toxicology. Dr. Yamaguchi has an interesting for cell signaling mechanism, bone biology, nutritional factor and osteoporosis prevention, diabetic osteoporosis, and cancer bone metastasis and osteolysis. Moreover, Dr. Yamaguchi discovered two novel proteins and genes; cell signaling suppressor protein (named regucalcin; 1978) and transcriptional factor RGPR-p117 (regucalcin gene promoter region-related protein; 2001) in mammalian cells. Dr. Yamaguchi generated regucalcin transgenic rats, which were registered as international patents (USA, EU, Japan, and Korea), and this animal is found to induce osteoporosis and hyperlipidemia. Recently, Dr. Yamaguchi proposes that regucalcin is a target molecule in carcinogenesis of various cancer cell types. Currently, the research of regucalcin is focused as a scientific topic. Dr. Yamaguchi published over 500 English articles to professional journals with peer-review. In addition, Dr. Yamaguchi registered over 20 national and international patents in the fields of his research interesting. Dr. Yamaguchi is serving as editors and editorial board members of reputed 40 international Journals. He received many honor and awards; Prize for Sato Memorial Fundation (1992, Japan/USA), Senji Miyata Foundation Award 2005 (Japan), Japan Society for Biomedical Research on Trace Elements Award 2007, The Lifetime Achievement Award from International Biographical Centre (IBC) (2004, England), The World Lifetime Achievement Award from American Biographical Institute (2004, USA), The Distinguished Service to Science Award from IBC (2007, England), and many others. Dr. Yamaguchi is listed in various biographies; Who’s Who in the World (2005-, Marquis Who’s Who, USA), Who’s Who in Sciences and Engineering (2004-, Marquis Who’s Who, USA), International Biographical Dictionary (2006-, IBC, England), and others.

 Biography
Research Interest :

Cancer and Oncology, Toxicology, Pharmacology

 Research Interest
 Network
Matteo A Russo

Matteo A Russo, PhD
Professor
Department of Experimental Medicine
University of Rome Sapienza
Italy
Tel. 390-649-970-806

Biography :

Matteo A Russo graduated in Medicine and Surgery (1969), Catholic University of Rome. Italy. He is Assistant Professor of General Pathology (1970),  University of Rome, Sapienza, Italy. Associate Professor of Experimental Oncology (1980), University of Rome, Sapienza. Full Professor of General Physiopathology (1986), University of Rome, Sapienza, Italy. Fulbright Scholar 1974-1976, University of Pennsylvania and Temple Univ, Phila., Pa., USA. Visiting Professor of Pathology, Thrombosis Center, Temple University, Phila (1977-1979). Adjunct Professor of Pathology and Pharmacology, (1980-1990). Temple University , Phila, Pa.USA. He has obtained many research grants, both in USA (US-Environmental Protection Agency#CR-808949 and WW Smith Charitable Trust) and Italy (MURST, CNR, AIRC, etc). Award for Experimental Oncology, Fondazione Assicurazioni Generali di Trieste (1982). Member of many scientific Societies (SIP, SIC, etc.) Member of the Superior Committee of Public Health.(2003-2005). Director of the Research Doctorate in Human Pathology of Univ of Rome, Sapienza. Malpighi award from the Malpighi and Holding International Altay Foundation (2005) Member of the National Committee for the Research of the Ministry of Health (2000-2009). Member of the Scientific Committee for the Excellence Centre of “Regione Lazio” (2006-). President of Biomedical Laboratory Technician School at Sapienza University of Rome. President of Ethical Committee of ASL of Frosinone, Italy (2004-2010) Member of Scientific Committee of IRCCS San Raffaele Pisana, Rome.

 Biography
Research Interest :

a) Mechanism of cell volume control independent from ATP-ase Na/K-dependent; b) Role of Ca2+ and cytoskeleton in the pathogenesis of necrosis and apoptosis; c) Cellular and molecular mechanisms of the consolidation of the white thrombus; d) Proinflammatory genes expression in tumor progression and in different human diseases; e) Mechanisms of molecular repair in post-mitotic cells: the role of endocrine, paracrin and mechano-coupled signaling and Sirtuins. He is the leader of three research groups of IRCCS San Raffaele Pisana, Rome, involved in building the molecular basis of mechano-coupled, electric-coupled and pharmaco-aided rehabilitation of skeletal muscle, myocardium, sensory receptors and neuronal paths.

 Research Interest
 Network
Anil Wali

Anil Wali, PhD
Program Director
National Cancer Institute
USA
Tel. 301-594-1628
Fax 301-435-9225

Biography :

Anil Wali  is a Program Director in the Diversity Training Branch for the Center to Reduce Cancer Health Disparities. He provides technical and scientific expertise and grants program administration guidance to trainees and early stage investigators. Dr. Wali joined CRCHD in 2009 from Wayne State University, Detroit Medical Center and NCI designated Comprehensive Cancer Center Barbara Ann Karmanos Cancer Institute where he served as Associate Professor in the Departments of Surgery and Pathology. Dr. Wali also served as Principal Investigator on a Veterans Administration Merit Review award funded project on the Role of Ubiquitin-Proteasome Pathway in Mesothelioma Carcinogenesis. Dr. Wali conducted NCI Clinical trial on asbestos exposed patient populations to determine their risk for developing Lung Cancer and Mesothelioma using high throughput Genomics and Proteomics technologies. Dr. Wali received his B.S. and M.S. degrees from the University of Kashmir, in Srinagar, India. He earned his Ph.D. at the Postgraduate Institute in Chandigarh, India. Dr. Wali completed postdoctoral training at the Institute for Environmental Medicine at the University of Pennsylvania at the FELS Institute for Cancer Research at Temple University, Philadelphia, PA and in the Department of Pathology at Thomas Jefferson University, Philadelphia, PA.

 Biography
Research Interest :

Lung Cancer, Genomics and Proteomics.

 Research Interest
 Network
Richard J Simpson

Richard J Simpson, PhD
Professor
Department of Biochemistry and Molecular Biology
University of Melbourne
Australia
Tel. 613-934-131-55
Fax 613-934-131-92

Biography :

Richard J Simpson is a Professor at University of Melbourne, Ludwig Institute for Cancer Research Parkville, Victoria, Australia.

 Biography
Research Interest :

Cancer Research.

 Research Interest
 Network
Mukesh Verma

Mukesh Verma, PhD
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
USA
Tel. (301) 594-7344
Fax (301) 435-6609

Biography :

Mukesh Verma is Chief of the Epidemiology and Genomics Research Program′s (EGRP). Dr. Verma joined EGRP as a Program Director in 2004. In 2005, he was appointed Acting Chief of EGRP′s former Analytic Epidemiology Research Branch (AERB). When EGRP reorganized in 2007, he was appointed Acting Chief of MTB and of the Host Susceptibility Factors Branch (HSFB), for which he served as Acting Chief through 2008. Before joining EGRP, he was a Program Director in NCI′s Division of Cancer Prevention (DCP). He also was Coordinator of DCP′s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs. He was on the faculty in the Biochemistry Department of Georgetown University before joining NIH.

 Biography
Research Interest :

Biomarkers, epigenetics, epidemiology technologies, proteomics, microRNA, methylation, mitochondria, nanotechnology, risk assessment, susceptibility factors, and systems genetics.

 Research Interest
 Network
Rajagopal Ramesh

Rajagopal Ramesh, PhD
Professor
Experimental Therapeutics & Translational Cancer Medicine
University of Oklahoma
USA
Tel. 405-271-6101 Extn.52501

Biography :

Rajagopal Ramesh  is a Cancer Research Working Group Member of AACR Chemistry (2006-present). American Association of Cancer Research (AACR) Member (1997-present). ASCO Associate Member (2006-present) NPA - National Postdoctoral Association Associate Member (2006-present).

 Biography
Research Interest :

Novel gene-based therapeutics using viral and non-viral vectors with emphasis on translational cancer research. 1) Development and testing of non-viral and nanoparticle-based gene delivery for cancer treatment, 2) Antitumor and anti-angiogenic properties of IL-24. Their findings have lead to Phase I clinical trials for treatment of solid tumors.

 Research Interest
 Network
Sanjay K Srivastava

Sanjay K Srivastava, PhD
Professor
Cancer Biology
Texas Tech University
USA
Tel. 806-356-4015; Extn: 319
Fax 806-356-4015

Biography :

Sanjay K Srivastava is a Professor of Biomedical Sciences at Texas Tech University Health Sciences Center (TTUHSC), Amarillo, Texas, specializing in cancer biology and nutritional chemoprevention. Prior to his arrival at TTUHSC in 2007, Dr. Srivastava served as an Assistant Professor in the Department of Pharmacology, University of Pittsburgh School of Medicine and was a full member of the University of Pittsburgh Cancer Institute. He also served as Research Scientist at Mercy Cancer Institute, Mercy Hospital of Pittsburgh and did his post-doc from University of Texas Medical Branch at Galveston, Texas. Dr. Srivastava received a B.S. in Physics, Chemistry & Math and a M.S. in Biochemistry from Lucknow University, India. His Ph.D. is in Biochemistry and Toxicology from Industrial Toxicology Research Center, Lucknow and Kanpur University, Kanpur, India. His research interests include cancer biology, chemoprevention of cancers by naturally occurring nutritional agents, chemical carcinogenesis and cell signaling. Dr. Srivastava is currently funded by two R01 grants from the National Cancer Institute, NIH. He has authored more than 100 research papers and book chapters and is a member of the American Association for Cancer Research, Society of Toxicology and AAPS. Dr. Srivastava is in the editorial board of several journals and ad-hoc reviewer of numerous scientific journals including Cancer Research, Carcinogenesis, Neoplasia and Molecular Pharmacology and also member of the study section of the National Institute of Health (NIH), Department of Defense and Susan G. Komen Breast Cancer Foundation. Dr. Srivastava has been recipient of several awards including TTUHSC “President’s Excellence in Research Award”. His research work has been featured by news agencies including BBC, MSNBC, CBS, ABC, Science News etc. and can be obtained from the following: BBC News-Pancreatic Cancer.

 Biography
Research Interest :

The molecular mechanisms of chemotherapeutic agents of natural origin against pancreatic, ovarian, and breast cancers.The long term goals of Dr. Srivastava’s research program are to: •Identify novel dietary or synthetic chemopreventive agents •Understand their mechanism of action at the cellular and molecular level •Explore their efficacy in vivo in preclinical experiments with suitable animal models and to verify changes in surrogate biomarkers •Investigate the synergistic effects of dietary agents with chemotherapeutic agents against cancer cells •Use the information obtained in preclinical studies to design and conduct phase I clinical trials •Establish pharmacokinetic data for the anticancer agents in humans, which will help to optimize further phase II/III chemoprevention trials.

 Research Interest
 Network
Paul Tchounwou

Paul Tchounwou PhD
Professor & Director
NIH RCMI Center for Environmental Health
Jackson State University
USA

Biography :

Paul Tchounwou is an Associate Dean of the College of Science, Engineering and Technology, Presidential Distinguished Professor & Director of the NIH RCMI-Center for Environmental Health and at Jackson State University, Jackson, Mississippi, USA. He earned his Sc.D. at Tulane University Medical Center (TUMC), New Orleans, Louisiana, USA. Currently, he is also Adjunct Professor at TUMC. He has published 134 peer-reviewed papers and book chapters, and made over 300 presentations at national and international conferences. He is currently Editor-In-Chief of International Journal of Environmental Research and Public Health (MDPI, Basel, Switzerland), and of Environmental Toxicology (John Wiley & Sons, New York, USA). He has taught toxicology, epidemiology, risk assessment and public health-related courses for more about 20 years. He is member of Delta Omega Honorary Public Health Society, American Association for the Advancement of Science, American Association for Cancer Research, American Public Health Association, National Environmental Health Association, Society of Toxicology, and New York Academy of Science. He is a reviewer of journals in the area of toxicology and health risk assessment. He has received several awards including the Millennium Award for Excellence in Research; National Role Model Award; AACR Faculty Scholar Award for Cancer Research and International Order of Merit.

 Biography
Research Interest :

Cellular and molecular mechanisms of metal-induced toxicity and carcinogenesis. Oxidative stress biomarkers associated with human exposure to toxic metals and pesticides. Apoptotic mechanisms and cell cycle modulation by chemotherapeutic drugs. Cytogenetic and mutagenic effects  associated with chemical exposure. Gene-environmental interactions in human diseases. Health risk assessment and management of hazardous substances.

 Research Interest
 Network
Chi-Yu Gregory Lee

Chi-Yu Gregory Lee, PhD
Professor
Obstetrics and Gynaecology
The University of British Columbia
Canada

Biography :

Chi-Yu Gregory Lee is a Professor in the Department of Obstetrics and Gynaecology, University of British Columbia, Columbia, Canada.

 Biography
Research Interest :

Research and Development of Antibody-Based Anti-Cancer Drugs. RP215 monoclonal antibody was shown to recognize specifically a carbohydrate-associated epitope located on the variable regions of cancer cell expressed immunoglobulins, designated in general as CA215.Structural elucidation of carbohydrate-associated epitope in CA215 which is recognized by RP215 monoclonal antibody (Mab). Humanizations of RP215 Mab for preclinical studies. Generations of Rat anti-idiotype Mabs as candidates for the development of anti-cancer vaccines in humans. Establishment of an Anti-GnRH receptor Mab, GHR106, as a substitute of short-acting GnRH analogs for antibody-based anti-cancer drugs, as well as preclinical studies. Elucidation of mechanisms of action for RP215 and GHR106 as antibody-based anti-cancer drugs. Elucidation of a carbohydrate-associated epitope recognized by RP215 monoclonal antibodies.

 Research Interest
 Network
Fernando Augusto Soares

Fernando Augusto Soares, PhD
Professor
Department of Anatomic Pathology
University of São Paulo
Brazil

Biography :

Fernando Augusto Soares is Full Professor at University of São Paulo, São Paulo, Brazil and Head of the Department of Anatomic Pathology of the research and Medical Hospital A.C. Camargo, São Paulo, Brazil. He also serves as Head of MSc and PhD program. He received his M.D. degree from Faculty of Medicine at Santos in 1980, and completed a residency in Pathology at University of State of São Paulo, Botucatu, Brazil. After that he moved to the University of São Paulo at Ribeirão Preto as teaching assistant in Pathology from 1984 to 1989 when received his Ph.D. degree, becoming Assistant Professor of Pathology at the same University. He was Visiting Professor at McMaster University at Hamilton, ON, Canada from 1991 to 1993. In 1997 become Head of the Department of Anatomic Pathology at Hospital A.C. Camargo and in 2004 received the title of Full Professor.He is a senior investigator in several grants which have resulted in more than 200 per-reviewed scientific papers in international journals.  Dr. Soares is also associate Editor of the upcoming Journal of Hematopathology, former President of the Brazilian Society of Pathology, and President of the Latin American Society of Pathology

 Biography
Research Interest :

Translational pathology with emphasis in biomarkers in diagnosis and prognosis of the tumors. His clinical expertise is in surgical pathology with emphasis in hematopathology.

 Research Interest
 Network
Song Xin

Song Xin, PhD
Professor
Tumor Biotherapy Center
Kunming Medical University
China
Tel. 868-718-100-739
Fax 868-718-100-739

Biography :

Song Xin is working as a Professor in the third affiliated hospital, Kunming Medical College, Kunming, China.

 Biography
Research Interest :

Signal transduction, Cell Cycle Biochemotherapy and  Molecular Carcinogenesis. Preclinical/clinical development of molecularly targeted cancer therapeutic agents and signaling networks, including molecular mechanism studies in vitro and in vivo of therapeutic agents and molecular carcinogenesis. Current research mainly focuses on investigation of the molecular and signaling transduction pathways.  Most agents are the regulators of signal transduction, cell cycle, apoptosis, angiogenesis, metastasis, differentiation, proteasome inhibition and DNA damage. Signal transduction including post translational modifications (acetylation, methylation, phosphorylation, cleavage) and molecular biologic events. The main signal transduction pathways he has studied are Ras/Raf/MEK/Erk, PKC/MAPK, PI3K/PKB/GSK3, NFk-B, PKA, proteasome, differentiation, cell cycle, caspase, cell death receptor, cell growth receptor, etc.

 Research Interest
 Network
Yu-Fei Jiao

Yu-Fei Jiao, PhD
Professor
Department of Pathology
Harbin Medical University
China

Biography :

Yu-Fei Jiao received the B.S. degree in clinical medicine from Harbin Medical University, Harbin, China in 1985 and the M.S. degree in pathology from Graduate School of Harbin Medical University, Harbin, China, in 1990. Moreover, he obtained the Ph.D. degree in laboratory medicine and pathology from Graduate School of Kochi Medical School, Kochi, Japan, in 1999.

 Biography
Research Interest :

Mechanisms of carcinogenesis and metastasis of the gastrointestinal cancer. Establishment of an enzymatic erythrocyte creatine assay to determine erythrocyte age and its clinical application. They established an enzymatic erythrocyte creatine assay, which is favorable for quantifying erythrocyte creatine, and has analytical characteristics suitable for routine work in clinical laboratories. Using this method, they investigated whether erythrocyte creatine can serve as a corrective index for HbA1c in patients with a shortened mean age of erythrocytes. Their study demonstrated that HbA1c decreased in inverse proportion to the increase in erythrocyte creatine because of a shortened mean age of erythrocytes, and that the abnormally decreased HbA1c value could be assessed with erythrocyte creatine. They also demonstrated that erythrocyte creatine can be used for predicting erythropoietic status and estimating hypersplenism in patients with liver cirrhosis.

 Research Interest
 Network
Jing Gung Chung

Jing Gung Chung, PhD
Professor
Biological Science and Technology
China Medical University
China
Tel. 886-422-053-366-2161
Fax 886-422-053-764

Biography :

Jing-Gung Chung is a Professor, Chairman, Department of Biological Science and Technology, China Medical University, Taichung, Taiwan (2002-2005) and Associate Professor, Department of Microbiology, School of Medicine, China Medical University, Taichung, Taiwan (1993-2002).

 Biography
Research Interest :

To Screen the Anticancer Activity of Compounds from Chinese Herbal Medicine and Natural Plants in Taiwan. Signal pathways of apoptosis which is induced by emodin in glima cancer cells. Regulation and function of drug resistance genes expression in cancer cells after exposed to examined agents.

 Research Interest
 Network
Sophia Ran

Sophia Ran, PhD
Associate Professor
Medical Microbiology, Immunology and Cell Biology
Southern Illinois University
USA
Tel. 217-545-7026

Biography :

Sophia Ran is an Associate Professor in the Department of Medical Microbiology, Immunology and Cell Biology at SIU School of Medicine and a member of the SIU Simmons Cancer Institute (SCI). Dr. Ran is a member of the American Association of Cancer Research (AACR). She is a coordinator of monthly research seminars in SCI, serves on the organizing committee for the bi-annual SCI Research Symposium as well as on various committees of the School of Medicine.

 Biography
Research Interest :

Breast cancer, Head & Neck cancer, Tumor Physiology, Tumor Angiogenesis, Hematogenous Metastasis, Tumor Lymphangiogenesis, Lymphatic Metastasis, Inflammation and Cancer, Inflammatory Lymphangiogenesis, Tumor Models in vivo, Chemotherapy & Chemoresistance, Regulation of Transcription, VEGF and Angiopoietins, VEGFR-1, VEGFR-2, VEGFR-3, Tie-1 and Tie-2 Receptors.

 Research Interest
 Network
Jagat R Kanwar

Jagat R Kanwar, PhD
Associate Professor
Immunology and Molecular Biomedical Research Institute
for Technology Research & Innovation
Deakin University
Australia
Tel. 006-135-227-1148

Biography :

Jagat R Kanwar is an immunologist and molecular biochemist with an international reputation in investigating fundamental and applied molecular aspects of cancer and chronic inflammation. He did his PhD from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Before joining Deakin University in 2006, he was a Senior Scientist/Senior Research Fellow in the University of Auckland, Auckland, New Zealand. During the past decade his research both academic and commercial has centered on understanding the pathophysiological mechanisms and/or finding treatments for a variety of chronic inflammatory diseases and different types of cancer. Dr. Kanwar has published 55 research articles, 12 invited reviews and 5 book chapters, in highly ranked, international, peer-reviewed journals. These publications have added to the body of knowledge in the fields of immunology, cancer gene therapy, nanomedicine, cell biology and biotechnology, and have extended these disciplines. He is a key inventor on 9 international patents and has provided consultancy to 5 Biotechnology based companies. He is a member of editorial board for 7 international journals and a nominated member of more than 12 national and international societies including American Society of Nanomedicine. He has extensive and close collaborations with colleagues from New Zealand, Australia, Singapore, India, China and USA.

 Biography
Research Interest :

Nanotechnology based drug delivery of proteins/peptides, siRNA and miRNA to target cancer and chronic inflammation drug discovery for novel anticancer targets for cancer cell survival, death, arrest, and repair development of immunomodulatory and anti-inflammatory bioactives, proteins and peptides for neuroprotection development of complementary alternative medicine from the milk derived proteins including metal binding protein (Lactoferrin), and herbal preparation derived active components with a special focus on the treatment of solid tumours (colon and breast cancers).

 Research Interest
 Network
Kailash C Chadha

Kailash C Chadha, PhD
Associate Professor
Molecular and Cellular Biology
Roswell Park Cancer Institute
USA
Tel. 716-845-3101
Fax 716-845-8389

Biography :

Kailash C Chadha is an Associate Member, Department of Molecular and Cellular Biology Roswell Park Cancer Institute Buffalo NY 14263 Associate Research Professor, Department of Cellular and Molecular Biology University of New York at Buffalo Roswell Park, Associate Professor of Oncology, Roswell Park Cancer Institute Buffalo, Research Professor Niagara University,  New York 14109 and Research Assistant Professor of Medicine, Department of Medicine School of Medicine State University of New York at Buffalo Buffalo NY 14214, USA.

 Biography
Research Interest :

During past 4 to 5 years, he has diverted most of my efforts in the area of prostate cancer research. (1) identification & development of new biomarkers for the early diagnosis and management of prostate cancer including androgen independent prostate cancer and (2) to determine the role of prostate-specific antigen (PSA) in regulating angiogenesis in prostate tumor growth & metastasis.

 

 Research Interest
 Network
Meena Upadhayaya

Meena Upadhayaya, PhD
Professor
Institute of Medical Genetics
Cardiff University
UK

Biography :

Meena Upadhayaya is Head of Department of Medical Genetics institute, School of Medicine, Cardiff University, UK.

 Biography
Research Interest :

The Genetics of Facioscapulohumeral Muscular Dystrophy, The Genetics of Neurofibromatosis.

 Research Interest
 Network
MM Misro

MM Misro, PhD
Professor
Reproductive Biomedicine
National Institute of Health & Family Welfare
India

Biography :

MM Misro is Professor in Reproductive Biomedicine in the National Institute of Health and Family Welfare, New Delhi, India. He is a postgraduate in Zoology with specialization in Physiology and Biochemistry and completed his Ph.D in Male reproductive Physiology with special emphasis in Contraceptive Technology Development. He was Fellow of Rockefeller Foundation and did his post doctoral training in the Department of Pharmacology in the University of Iowa during 1984-1986. He is currently a member of the Editorial Board in the International Journal “Current Women’s Health Reviews and peer reviewer for many International Journals.

 Biography
Research Interest :

The processes of molecular regulation of germ cell apoptosis in the seminiferous epithelium.

 Research Interest
 Network
Michael Eckart

Michael Eckart, PhD
Director
Protein and Nucleic Acid Facility
Stanford University
USA
Tel. 650-723-1907
Fax 650-725-4951

Biography :

Michael Eckart is a Director of Protein and Nucleic Acid facility at Stanford University, USA.

 Biography
Research Interest :

Protein/Peptide Chem Edman Sequencing, Peptide Synthesis, Physical Chemistry, SPR, Nucleic Acid Chemistry, DNA Sequencing DNA Synthesis, Gene Array, Genotyping, Real Time PCR, RNA Synthesis, Mass spectrometry MS-Nucleic Acids, MS-Proteins-Intact, Peptide Mass Mapping, Other Carbohydrate Analysis.

 Research Interest
 Network
Chulso Moon

Chulso Moon, MD, PhD
Director
Department of Medical Oncology
The South Western Medical Center
USA
Tel. 158-053-164-00
Fax 158-053-146-81

Biography :

Chulso Moon is having 1. Tenure Track Professorship in the Department of Oncology, Otolaryngology, Head and Neck Surgery, The Johns Hopkins University School of Medicine (2001-2007). 2. Principal Investigator, The Head and Neck Cancer Research Institute, The Johns Hopkins University School of Medicine (Director: Dr. David Sidransky) (2001-). 3. Attending physician, The Johns Hopkins Hospital (2001-2006). 4. Principal investigator, ONXY-015 cancer genetherapy program for advanced head/neck cancer (2001-2003). 5. Adjunct Professorship, Department of Otolaryngology and Head and Neck Surgery, The Johns Hopkins University school of Medicine (2008- Present). 6. Preceptor, Graduate Program in Human Genetics and Molecular Biology, The Johns Hopkins University school of Medicine (2005- Present, Thesis Advisor for Juna Lee, 2010 Ph.D. Candidate). 7. Director of Medical Oncology, Cleo Craig Memorial Cancer Clinic, The South-Western Medical Center, Lawton OK (2010-Present).

 Biography
Research Interest :

Cancer gene therapy.

 Research Interest
 Network
Gary Guishan Xiao

Gary Guishan Xiao, PhD
Director
Genomics and Functional Proteomics Laboratories
Creighton University
USA
Tel. 402-280-5911
Fax 402-280-4284

Biography :

Gary Guishan Xiao is a Director of the Functional Genomics and Proteomics laboratories at the Creighton University. Osteoporosis Research Center, is an internationally recognized expert in the field of proteomics and metabolomics of cancers and bone disease. Dr. Xiao earns his Ph.D. in molecular computational biology about a dozen years ago, focusing on structural modeling of ligand-enzyme interaction and prediction of protein refolding pathways during protein translational process. Dr. Xiao had his postdoctoral research trained in Baylor College of Medicine and UCLA, focusing on pharmacokinetics and biochemistry of non-steroid inflammatory drugs such as aspirin-derivatives and their target, human prostaglandin H synthases H1 and H2, and cell cycle regulation, especially, the role of c-Myc in cardiac termination differentiation. Dr. Xiao’s research at harbor UCLA medical Center and City of Hope National Cancer Center were highly focused on genomic and proteomic interpretations of diet-induced obesity/diabetes and its complications such cancers and osteoporosis. Dr. Xiao joined Osteoporosis Research Center at the Creighton University Medical Center since 2007. Dr. Xiao has been regular reviewer or ad hoc reviewer for several medial journals, different funding agency such as NIH and several journal Editorial Board members.

 Biography
Research Interest :

Functional genomics & proteomics analyses of complex disease Including osteoporosis and cancer (especially, breast cancer, pancreatic cancer and prostate cancer). Function of microRNA in estrogen signaling, functional proteomics (focusing on the role of protein posttranslational modifications in cancer and osteoporosis), and proteomics technology development.

 Research Interest
 Network
Honglin Zhou

Honglin Zhou, MD, PhD
Associate Director
Department of Emergency Medicine
University of Pennsylvania
USA
Tel. 215-746-8938
Fax 215-746-1224

Biography :

Honglin Zhou is an Associate Director of Center for Resuscitation Science Translational Research Laboratory (TRL) at University of Pennsylvania Philadelphia.

 Biography
Research Interest :

Cancer Science.

 Research Interest
 Network
Demir Akin

Demir Akin, DVM, PhD
Deputy Director
Radiology - Nuclear Medicine
Stanford University
USA

Biography :

Demir Akin Congretionally Directed Medical Research Programs, Breast Cancer Research Program, National Cancer Institute, Alliance for Nanotechnology in Cancer,  Radiation Oncology Program, CDMRP/DoD,  American Association for Cancer Research (AACR), U.S. Civilian Research and Development Foundation (CRDF).

 Biography
Research Interest :

Biological Engineering and Micro/Nanomedicine, Genomics/Systems Biology, Gene Therapy/Microbiology/Virology.

 Research Interest
 Network
Ardeshir Hakam

Ardeshir Hakam, MD, MBA
Associate Professor
Oncologic Sciences & Pathology
University of South Florida
USA
Tel. 813-745-1874
Fax 813-745-1708
Read Interview session with Ardeshir Hakam

Biography :

Ardeshir Hakam is an Associate Professor of Oncology, Pathology and cell biology. Currently, he is Director of Surgical Pathology at Moffitt Cancer Center and research institute and Program Director of Oncologic Surgical Pathology Fellowship at the University of South Florida. Dr. Hakam is a board certified Pathologist and Cytopathologist. His training includes Anatomic & Clinical Pathology Residency at University of Hawaii, school of Medicine and fellowship trainings in Genitor-urinary pathology at University of Pittsburgh Medical Center and Oncologic Pathology and Cytopathology at University of South Florida, College of Medicine. He has published many peer reviewed articles, and abstracts in national meetings.

 Biography
Research Interest :

Gynecological and urological malignancies.

 Research Interest
 Network
Sun Jianguo

Sun Jianguo, PhD
Director
Xinqiao Hospital
Third Military Medical University
China
Tel. 862-368-774-490

Biography :

Sun Jianguo is a Director of Oncology Institute, Xinqiao Hospital, Third Military Medical University, Chongqing, China.

 Biography
Research Interest :

MicroRNA in carcinogenesis and cancer stem cell-related microRNAs, lung cancer.

 Research Interest
 Network
Prakash Nagarkatti

Prakash Nagarkatti, PhD
Department of Pathology
University of South Carolina
USA
Tel. 803-733-3180
Fax 803-733-3335

Biography :

Prakash Nagarkatti is currently an Associate Dean for Basic Science, Advisor to the Vice President for Research, and Carolina Distinguished Professor at the University of South Carolina School of Medicine. He received his Ph.D. degree from the Defense Research and Development Establishment and Jiwaji University in 1981 and pursued a post-doctoral fellowship at McMaster University. He is also the Director of NIH-funded Center of Research Excellence on Complementary and Alternative Medicine in Autoimmune and Inflammatory Diseases. He has held faculty positions at the University of Kentucky, Virginia Tech and Virginia Commonwealth University. He has received numerous awards from the International Congress of Mucosal Immunology, Society of Toxicology, and the Virginia Academy of Sciences. He has served as a Chair of several NIH Study Sections, Editorial Boards of journals and a reviewer for several national and international funding agencies. His research has generated more than $20 million and he has published over 140 papers.

 Biography
Research Interest :

Cancer Immunology and Immunotherapy, Complementary and Alternative Medicine, Inflammation, Autoimmune Diseases, Drug abuse research, Immunotoxicology, Environmental toxicology, Developmental Immunology, Cannabinoids.

 Research Interest
 Network
Gloria I Sanchez

Gloria I Sanchez, PhD
Associate Professor
Group Infection and Cancer Lab
University of Antioquia
USA
Tel. +57-(4)-219 6062

Biography :

Gloria I. Sanchez is an Associate professor in the School of Medicine at the University of Antioquia in Medellin, Colombia and leader of the research group Infection and Cancer. She earned her Ph.D. in Molecular Microbiology and Immunology from the Johns Hopkins Bloomberg School of Public Health in 2000 at which time she joined the University of Antioquia where she started a research program focusing on the area of Human Papillomavirus (HPV) and Cancer. From 2004-2006, she completed Postdoctoral Fellowships at the Catalan Institute of Oncology in Barcelona, Spain, at the Department of Internal Medicine and Human Genetics at University of Michigan, Ann Arbor Michigan. During postdoctoral training, she participated in a multicenter worldwide study defining the time trends of HPV infection in cervical cancer and defining the role of HPV on Head and Neck and other human cancers.

 Biography
Research Interest :

Since 2000 Dr. Gloria I. Sanchez has been conducting research on various aspects of HPV-induced carcinogenesis. High-Risk  Human Papillomavirus (HR-HPV) infection has been recognized as the necessary cause for cervical carcinoma. The lifetime incidence of cervical infection is estimated to be as high as 80% and almost 50% of women acquire HPV infection shortly after sexual debut but about 90% of these infections clear in around 1-2 years. Only infections that persist progress to dysplasia and cervical cancer.

Current research is designed to understand how cofactors can influence the probability of HPV to become a persistent infection with particular attention to 1. Understand the contribution of HPV 16 variants and cell-mediated immune response mechanisms as risk factors for HPV persistence and cervical carcinogenesis. 2. To find new biomarkers of HPV persistence and cervical cancer. 3. To study the clinical application of new molecular biomarkers for risk stratification of HR-HPV positive women.

 Research Interest
 Network
Mitchell Ho

Mitchell Ho, PhD
Head
Antibody Therapy Unit
National Cancer Institute
USA
Tel. 301-451-8727
Fax 301-480-4667

Biography :

Mitchell Ho is an Investigator and Head of the Antibody Therapy Unit in the Laboratory of Molecular Biology at the National Cancer Institute (NCI). Dr. Ho received his Ph.D. from the University of Illinois at Urbana-Champaign, where he studied monoclonal antibodies for the treatment of cocaine addiction as a National Research Service Award Fellow with Mariangela Segre. He completed postdoctoral studies with Ira Pastan at the NCI working on immunotoxin therapy of cancer. Research in Dr. Ho’s laboratory studies mesothelin, CA125/MUC16 and other cell adhesion molecules as therapeutic targets in order to develop novel antibodies and immunoconjugates to treat ovarian cancer, mesothelioma and liver cancer. He has developed the mammalian cell display method which is currently being used by investigators worldwide to identify and engineer therapeutic antibodies. Dr. Ho is a recipient of Mesothelioma Applied Research Foundation Award, and Ovarian Cancer Research Fund Individual Investigator Award.

 Biography
Research Interest :

Ovarian cancer, liver cancer.

 Research Interest
 Network
Dongfeng Wu

Dongfeng Wu, PhD
Associate Professor
Bioinformatics and Biostatistics
University of Louisville
USA
Tel. 502-852-1888
Fax 502-852-3294

Biography :

Dongfeng Wu is a Member of American Statistical Association (ASA)International Biometric Society-East North American Region (ENAR) Editorial Services Editorial board member, Journal of Biometrics and Biostatistics;Editorial board member, Journal of Modern Applied Statistical Methods.Ad-hoc Member/Reviewer a. National Institute of Health (NIH), Special Emphasis Panel ZRG1 PSE-C (58) and ZRG1 PSE-J (58) R, challenge grant proposals review, May 2009. b. Judge for Research!Louisville, 2008, 2009. c. Educational Testing Service (ETS) AP reader of Statistics, June 5-11, 2009. d. Chaired a session at the Joint Statistical Meeting (JSM)2006, Seattle, WA, and section title: “Spline-based methods.”Referee Statistics in Medicine; Information Sciences; Quality of Life Research; Cancer; Statistical Methodology; Printice Hall; W.H. Freeman and Company. Other Services: At University of Louisville, SPHIS Faculty Forum Committee member, School Academic Affair Committee member, School Curriculum Committee member; Department of Bioinformatics and Biostatistics Master’s Program Director. At Mississippi State University, University Academic Review Board, 2002-03, University of  Grievance Panel, 2005-2007, Departmental Statistics Committee, Departmental Computing and Technology Committee, Departmental Assessment Committee, Departmental Evaluation of Teaching Assistants Committee.

 Biography
Research Interest :

Cancer screening, Stochastic modeling, Wavelet regression, Bayesian inference, Smoothing spline, Statistical decision theory, Time series.

 Research Interest
 Network
Qingrong Huang

Qingrong Huang, PhD
Associate Professor
The State University
Princeton Junction
New Brunswick, NJ, USA

Biography :

Qingrong Huang is an Associate Professor, Department of Food Science, Rutgers University at New Brunswick. 9/2008-8/2009 Cluster Coordinator, Nanotechnology Application to Foods Cluster, Center for Advanced Food Technology, Rutgers University 1/2008-present, Full member of Graduate Programs in Molecular Biosciences, UMDNJ/Rutgers University, and Department of Molecular Biology & Biochemistry-Rutgers 1/2003-present, Full member of Graduate Program in Bioresources Engineering-Rutgers University at New Brunswick. 9/2002-6/2008, Assistant Professor, Department of Food Science, Rutgers University at New Brunswick. 1/2000-8/2002, NIST ATP Postdoctoral Research Associate, Department of Chemical Engineering, Stanford University/IBM Almaden Research Center  Advisors: Drs. Curtis Frank and Robert Miller 2/1999-3/1999 Visiting Scientist, Intense Pulsed Neutron Source Division, Argonne National Laboratory. 6/1998-1/2000, Postdoctoral Research Associate, Department of Chemistry, Indiana-Purdue University, Advisor: Dr. Paul Dubin2 8/1993-5/1998, Research/Teaching Assistant, Department of Chemistry, University of Nebraska-Lincoln. 9/1989-7/1993, Research Assistant, Laboratory of Polymer Physics, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences. 2010 American Chemical Society Young Scientist Award finalist. Distinguished Speaker, College of Agricultural, Consumer & Environmental Sciences, University of Illinois, November 19, 2009. Received 2007-2008. The Professor Endel Karmas Award for Excellence in Teaching Food Science, Department of Food Science, Rutgers University. Honorable Speaker for the Polymer Science Lecture Series, State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, May, 2007. Honorable Speaker for the Polymer Science Lecture Series, State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, May, 2006.

 Biography
Research Interest :

Food Nanotechnology and biopolymers, with specific research interest in: (1) structure and self-assembly of biopolymers; (2) development of nanoemulsion/nanoparticle-based, controllable, traceable, and targetable nutraceuticals/drug delivery systems; (3) nutraceutical/protein (including receptor proteins) interactions, protein/carbohydrate interactions; (4) chemical force microscopy/single molecular force spectroscopy; (5) small-angle neutron/x-ray scattering, dynamic light scattering, surface laser light scattering, rheology; and (6) DNA and antibody-based biosensors.

 Research Interest
 Network
Hiranmoy Das

Hiranmoy Das, PhD
Associate Professor & Director
Cardiovascular Stem Cell Research Laboratories
The Ohio State University
USA
Tel. (614) 688-8711
Fax (614) 293-5614

Biography :

Hiranmoy Das is an Associate Professor of Medicine & Director of Cardiovascular Stem Cell Research Laboratories, The Ohio State University, Columbus, USA.

 Biography
Research Interest :

Stem cell therapy using autologous stem cells to treat degenerative diseases is promising; however, the limited availability and compromised quality of progenitor cells in aged and diseased patients limit its therapeutic potential. Alternatively, use of cord blood-derived stem cells is advantageous as it is easy to harvest, harmless to donor, ethical, ontogenetically primitive and can be stored in cord blood bank for years.

Current investigation focuses on the role of KLF2 in the genetically altered murine model in the context of rheumatoid arthritis.

 Research Interest
 Network
Porunelloor A Mathew

Porunelloor A Mathew, PhD
Associate Professor
Molecular Biology and Immunology
University of North Texas
USA

Biography :

Porunelloor A Mathew is an Associate Professor of Molecular Biology and Immunology, University of North Texas Health Science Center at Fort Worth, and Associate Director for basic research, Institute for Cancer Research, UNTHSC, Fort Worth, Texas. Dr. Mathew received his PhD in Biochemistry in 1987 from University of Pune, India. He did postdoctoral fellowships at University of Medicine and Dentistry of New Jersey and UT Southwestern Medical Center. He is a reviewer for several journals. Dr. Mathew was awarded a US patent for “Immuno activation of CS1 receptor in Natural Killer cells to inhibit tumor cell growth”. Dr. Mathew’s research has opened new NK cell based targeted immunotherapy for cancer.

 Biography
Research Interest :

Cancer immunology, Natural Killer cell receptors, Molecular basis of NK cell recognition and activation by tumor cells. Regulation of immune response by surface receptors, Role of NK receptors in autoimmune diseases (systemic lupus erythematosus) targeted immunotherapy for cancer.

 Research Interest
 Network
Rajasekhar NVS Suragani

Rajasekhar NVS Suragani, PhD
Cell Biology Discovery Group
Acceleron Pharma
USA
Tel. 617-649-9343

Biography :

Rajasekhar NVS Suragani has been working at Cell Biology Discovery Group, Acceleron Pharma, Cambridge, USA.

 Biography
Research Interest :

Cancer biology.

 Research Interest
 Network
Rui Hai Liu,

Rui Hai Liu, MD, PhD
Associate Professor
Department of Food Science
Cornell University
USA

Biography :

Rui Hai Liu has published more than 90 original scientific papers in peer-reviewed journals with average citations of 46.87 per paper. He has been ranked as one of the top 5 scientists by total citations, and ranked No. 4 by impact, average citations per paper (49.45), among the scientists in the field of Agricultural Sciences (including Nutrition and Food Science) by Institute of Scientific Information (ISI), in the January 1, 2000–February 28, 2010 time period. He has given more than 200 invited seminars and research presentations throughout the US and around the world. Dr. Liu was elected as a Fellow of the International Academy of Food Science and Technology (IAFoST) in 2008. He is also an elected Fellow of the Division of Agricultural and Food Chemistry (AGFD) of the American Chemical Society (ACS) in 2008, and elected Fellow of the Institute of Food Technologists (IFT) in 2010.

 Biography
Research Interest :

Diet and cancer, the effects of functional foods/nutraceuticals on chronic disease risks, and bioactive compounds in natural products and herbal remedies for anticancer and antiviral activity.  Specific interests include: 1) health benefits of antioxidants/phytochemicals in fruits, vegetables and whole grains; 2) food genomics and functional foods for disease prevention and health promotion targeted at cancers, aging, and inflammatory diseases; and 3) natural products and herbal formulations for antiviral activity to hepatitis B and C.

 Research Interest
 Network
Zhou B Peter

Zhou B Peter, PhD
Associate Professor
Department of Molecular & Cellular Biochemistry
University of Kentucky
USA

Biography :

Zhou B Peter received extensive training in breast cancer research at the Department of Molecular and Cellular Oncology and Breast Cancer Research Program at the MD Anderson Cancer Center prior to the faculty appointment at UTMB and UK Markey.

 Biography
Research Interest :

Breast cancer metastasis, particularly the biology underlying the process of Epithelial-mesenchymal transition (EMT). In these EMT processes, epithelial cells acquire fibroblast-like properties and exhibit reduced intercellular adhesion and increased motility. Activation of this normally latent EMT program confers cancer cells a distinct advantage for invasion and metastasis to distant organs or tissues. Using biochemical and molecular approaches, my group is characterizing the functional roles of Snail and Twist, two major inducer of EMT, in breast cancer metastasis. Uncover altered signaling pathways that regulate metastasis in breast cancer and, by discovery these pathways, to identify molecules that may serve as the therapeutic targets for metastasis prevention

 Research Interest
 Network
Sharad Singhal

Sharad Singhal, PhD
Associate Professor
Molecular Biology and Immunology
University of North Texas
USA
Tel. 817-735-2236
Fax 817-735-2118

Biography :

Sharad Singhal is a recipient of Junior Research Fellowship of council of Scientific and Industrial Research, 1985-1987.­ Recipient of Senior Research Fellowship of Council of Scientific and Industrial Research, 1987-1989.­ Postdoctoral Fellow, Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas, 1989-1992.­ Instructor, Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas, 1992-1997.­ Assistant Professor, Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas, 1997- Feb 1999. Arlington, Arlington, TX  March 1999- October 2004. Arlington, Arlington, TX  November 2004-November 2007.­ Associate Professor, Department of Molecular Biology and Immunology, University of North Texas Health Science Center, Forth Worth, TX  December 2007-Present.

 Biography
Research Interest :

Multi-drug resistance in cancer, liposomal delivery, radiation poisoning, stress signaling and oxidative stress, carcinogenesis, syngeneic and xenografts model, role of RLIP76 in regulation of glycemic control.

 Research Interest
 Network
Yanming Wang

Yanming Wang, PhD
Associate Professor
Department of Radiology
Case Western Reserve University
USA

Biography :

Yanming Wang is an Associate Professor of the Department of Radiology, Director of Radiopharmaceutical Division, Case Center for Imaging Research Case Western Reserve University Cleveland, USA.

 Biography
Research Interest :

Alzheimer’s association, cancer research.

 Research Interest
 Network
Pratap Kumar

Pratap Kumar, PhD
Associate Professor
Department of Urology
The University of Texas Health Science Center
USA
Tel. (210) 567-5647
Fax (210) 567-6868

Biography :

Pratap Kumar is an Associate Professor of the Department of Urology, The University of Texas Health Science Center at San Antonio, TX, USA. As a member of the Editorial Board, he assists in establishing editorial policy for the journal and in evaluating the material which has been submitted by others in the field of cancer science for publication in the journal. This will entail several peer reviews a year and responsibilities to select other expert to review articles. Dr Kumar was chosen as member of the Editorial Board on the basis of his expertise in the field of molecular cancer prevention especially exploiting natural products in conjunction with standard of care with special reference to Genitourinary and gastrointestinal malignancies.

 Biography
Research Interest :

Molecular cancer, genitourinary and gastrointestinal malignancies.

 Research Interest
 Network
Rajendra Sharma

Rajendra Sharma, PhD
Associate Professor
Molecular Biology and Immunology
University of North Texas
USA
Tel. 817-735-2140
Fax 817-735-2118

Biography :

Rajendra Sharma was a Research fellow, Rajasthan University, Jaipur, India (1975-1979). Synthesized 3,4:6,7-dibenzomorphans, the compounds related to 6,7- benzomorphans (potent analgesics). Evaluated pharmacological efficacy of substituted 3,4:6,7-dibenzomorphans Research Associate, All India Institute of Medical Sciences, New Delhi (1980-1981) Investigated the energetics of radiation induced DNA damage and its repair mechanisms in normal and cancer cells. Identified relationship between DNA repair and the rate of cellular energy supply. Post-doctoral fellow (1989-1991) Purified and characterized a novel membrane transport protein DNP-SG ATPase from human erythrocytes. Established involvement of DNP-SG ATPase in the transport of glutathione conjugates of electrophilic compounds in humantissues. Showed the expression of DNP-SG ATPase in different human tissues. Purified and characterized glutathione S-transferases from mammalian tissues. Suptdg. Chemist at KDMIPE, Dehradun, India ( April 1991- March 2000)Analyzed pollutants from the surrounding areas of oilfields of Indian sedimentary basins.Investigated the toxic impact of petroleum hydrocarbons on human tissues.Visiting Scientist at UTMB, Galveston, TX (April 2000-Sept. 2003) Stably transfected cultured cells (HLE B-3) with human glutathione S-transferase A4 gene and demonstrated role of 4-hydroxynonenal in cell cycle and apoptotic signaling.Purified and characterized recombinant human RLIP76 a non-ABC transport protein and demonstrated a major role of RLIP76 in the ATP-dependent transport of glutathione-conjugates and chemotherapeutic agents in human erythrocytes and cultured cells.Suptdg, Chemist at KDMIPE, Dehradun, India (Oct 2003- Aug.2005): Team leader- Project entitled “DNA finger printing technique in oil exploration”.

 Biography
Research Interest :

1. To investigate the detoxification mechanisms of xeno- and endo-biotics by glutathione linked phase II enzymes particularly GSTs as well as their role in protection against oxidative stress.2. Role of 4-HNE in cellular signaling related to apoptosis, cell proliferation and transformation and modulation of its intracellular concentration by coordinated action of GSTs and RLIP76.3. Chemoprevention of Cancer by natural products: These studies are focused on the role of lipid peroxidation in the mechanisms of cancer prevention and cell killing by sulforaphane, curcumin and Withaferin A.

 Research Interest
 Network
Liang Xu

Liang Xu, PhD
Associate Professor
Molecular Biosciences
University of Kansas
USA
Tel. 785-864-5849
Fax 785-864-1442

Biography :

Liang Xu is an Associate Professor in the Department of Molecular Biosciences at University of Kansas.

 Biography
Research Interest :

Molecular therapy targeting cancer and cancer stem cells, cancer biology, drug discovery and drug/gene delivery. Funded by multiple NIH and DOD grants, my lab is working on molecularly targeted cancer therapy and chemo/radiosensitization by modulating cell death signaling pathways, autophagy and apoptosis. We are exploring microRNAs as novel targets for cancer and cancer stem cells. Novel nanotechnology to develop nanovectors targeting cancer cells for siRNA/miRNA-based novel cancer therapeutics. Nanovectors targeting cancer stem cells and exploring novel molecular therapy for cancer stem cells.

 Research Interest
 Network
Jasvinder A Singh

Jasvinder A Singh, MD, MPH
Associate Professor
Medicine and Epidemiology
University of Alabama
USA
Tel. 205-996-5855
Fax 205-996-9685

Biography :

Jasvinder A Singh is a rheumatologist-epidemiologist at the University of Alabama at Birmingham and a staff physician at the Birmingham Veterans Affairs Medical Center. 

 Biography
Research Interest :

Systematic reviews and meta-analyses of treatments for arthritis, outcomes research in patients with osteoarthritis, gout and joint replacement focused on patient-reported outcomes, quality of care assessment and development of treatment recommendations and quality indicators.

 Research Interest
 Network
Yonghe Li

Yonghe Li, PhD
Associate Professor
Department of Pharmacology
University of Alabama
USA
Tel. 205-581-2750
Fax 205-581-2093

Biography :

Yonghe Li joined Southern Research Institute as an Advanced Research Biochemist in 2005 after working as a Research Instructor at Washington University. He also currently serves as an adjunct Associate Professor of Pharmacology and Toxicology at The University of Alabama at Birmingham (UAB) and is a member of the UAB Comprehensive Cancer Center. Dr. Li received his B.S. in Pharmacology from Shanghai Medical University in China and his Ph.D. in Biochemistry from James Cook University in Australia. He completed his postdoctoral training in cell biology at Washington University School of Medicine in St. Louis.

 Biography
Research Interest :

Wnt Signaling in Cancer, canonical Wnt signaling pathway is important in stem cell biology and embryonic development and can lead to tumor formation when aberrantly activated. Defining the roles of Wnt co-receptor LRP6 and its regulators in cancer tumorigenesis and metastasis.

 Research Interest
 Network
Konda Mohan Reddy

Konda Mohan Reddy, PhD
Associate Professor
Department of Pediatrics and Pediatric
Endocrinology and Metabolism
University of Central Florida
USA
Tel. 407-896-2901

Biography :

Konda Mohan Reddy is a board-certified pediatric endocrinologist and specializes in pediatric health issues related to growth, puberty, metabolism and diabetes. He is a noted expert on pediatric endocrinology, speaking regularly around the country and the world about pediatric endocrine and metabolic disorders. He was invited to be a keynote speaker at the World Congress of Endobolism in Beijing China in 2012. Dr. Reddy and the medical team at Florida Center for Pediatric Endocrinology, Diabetes & Metabolism offer comprehensive treatment and education to children with diabetes, hormone and growth-related problems.

 Biography
Research Interest :

• Metabolic Syndrome in PCOS: Precursors and Interventions • A Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Sitagliptin in Adolescents with Type 2 diabetes • Small for gestational age: The role of IGF- 1 • Functional effects of Tescalcin gene. • Comparison of a Needle-free Injection Method (T-jet™) With a Needle-syringe Injection Method for the Delivery of Tev-Tropin® in Pediatric Subjects With Human Growth Hormone Deficiency.

 Research Interest
 Network
Girja Shanker Shukla

Girja Shanker Shukla, PhD
Associate Professor
Department of Surgery
University of Vermont
USA
Tel. 802-656-9488(O)/802-656-3655(L)
Fax 802-656-5833

Biography :

Girja Shanker Shukla is an Associate Professor in the Department of Surgery, University of Vermont, USA.

 Biography
Research Interest :

37 years of research experience in Biochemistry, Cell and Molecular Biology, which include the last 10 years of experience in Targeted Cancer Therapy.

 Research Interest
 Network
Rayudu Gopalakrishna

Rayudu Gopalakrishna, PhD
Associate Professor
Department of Cell and Neurobiology
USC Keck School of Medicine
University of Southern California
USA
Tel. (323) 442-1770
Fax (323) 442-1771

Biography :

Rayudu Gopalakrishna is an Associate Professor in the Department of Cell and Neurobiology USC Keck School of Medicine, USA.

 Biography
Research Interest :

Major Areas of Research Interest:
-Ca2+-dependent cellular regulation
-Protein kinase C and protein phosphatases
-Tumor promoters and chemopreventive agents
-Oxidative stress and free radicals
-Pharmacological aspects of cancer metastasis
Research in Progress:
-Oxidative regulation of protein kinase C by tumor promoters
-Cancer chemopreventive antioxidants
-Green tea signaling mechanisms in neurite outgrowth (with Tom McNeill)
-Selenium in prostate cancer prevention

 Research Interest
 Network
Eldad Zacksenhaus

Eldad Zacksenhaus, PhD
Professor
Department of Medicine
University of Toronto
Canada
Tel. 416-340-4800x5106
Fax 416-340-3453

Biography :

Eldad Zacksenhaus is an Associate Professor in the Department of Medicine, Department of Laboratory Medicine & Pathobiology and the Department of Medical Biophysics, University of Toronto.

 Biography
Research Interest :

Breast cancer and the tumor suppressor pRb pathway

 Research Interest
 Network
Pavol Zubor

Pavol Zubor, PhD
Associate Professor
Obstetrics and Gynecology
Comenius University
Slovak Republic, Europe
Tel. 004-214-342-035-46

Biography :

Pavol Zubor is an Associate Professor of the Department of Obstetrics and Gynecology.

 Biography
Research Interest :

1. Gene expression profiling in histologically normal breast gland epithelium, breast cancer or breast fibroadenoma tissue from breast cancer/fibroadenoma patients. Research is focused on conditions between surrounding tissue and tumor profile in the linkage to the tumor origin using samples microdissected from preoperative core and definitive excisional biopsied tissue, as well. 2. Analysis of genetic loci (polymorphic sites or somatic changes/mutations) associated with breast or gynecological cancer risk and biological profile of the disease. 3. Development of sensitive methods for detecting of somatic mutations and epigenetic changes (e.g. methylation) in breast, endometrial and ovarian cancer tissues based on direct DNA sequencing, Taqman assay and high resolution melting analysis. 4. E6/E7 mRNA oncogenesis + other molecular markers expression analysis in women with premalignant and invasive cervical lesions. 5. FISH telomerase expression in cervical premalignant lesions and carcinomas.6. Determination of serum levels of circulating cell-free cancer DNA (cfDNA) and micro RNA.

 Research Interest
 Network
Nives Pecina Slaus

Nives Pecina Slaus, PhD
Professor
Department of Biology
University of Zagreb
Croatia 
Tel. 385-146-211-40
Read Interview session with Nives Pecina Slaus

Biography :

Nives Pecina-Slaus is an Associate professor at the department of biology and Head of the Laboratory of Neuro-oncology Croatian Institute for Brain Research Medical School, University of Zagreb. She has received her B.S. in 1990. her M.S. in 1992. from the University of Zagreb, Faculty of Math and Sciences, and her Ph. D. in the field of molecular oncology in 1998 from Medical School University of Zagreb. She was trained at Cold Spring Harbor Laboratory Undergraduate Research Program, New York, USA in 1990; Georgetown University, Washington DC, USA in 1991; at the Division of Molecular Medicine at the Ruder Boškovic Institute in Zagreb in 1993. She joined Croatian Institute for Brain Research team in 2003 and in 2004 was appointed Head of the Laboratory of Neurooncology Croatian Institute for Brain Research, Zagreb. In 2005 she was elected Senior Investigator (scientific rank of full professor) and in 2007 associate professor at the Department of Biology, School of Medicine. She teaches Medical biology and was mentor on numberous theses. She was granted and was/is leading as prinicpal investigator five scientific projects. Her resarch has led to publication of more than 100 publications - scientific papers, a book, abstracts and book chapters. Her main fields of reseach are cancer genetics, Wnt signaling pathway, brain tumorigenesis, tumor suppressor genes, oncogenes, genetic profiles of brain tumors. She acts as a reviewer for Ministry of Science, Education and Sports Croatia, for Slovenian Research Agency (ARRS) for National council for university education, many scientific peer-reviewed journals (Brain Research, The Journal of Pediatric Biochemistry; International Orthopaedics, European Spine Journal, Journal of Pediatric Neurology, Kidney International, PLOSOne; Genes and Cancer, Lijecnicki vjesnik, Croatian Medical Journal). She is a member on editorial boards of scientific journals Frontiers in Bioscience, Acta Clinica Croatica, Cancer Cell International and Scientific Advisory Board of Melanoma Molecular Project Map and member of the review board of Journal of Pediatric Biochemistry, Journal of Chinese Clinical Medicine, Journal of Pediatric Neurology. She was awarded two scientific awards by Croatian Medical Association and Academy of Medical Sciences for best paper in basic medical research for young scientist. She is a member of Croatian Society of Human Genetics, Croatian Medical Association, Croatian Biological Society, European Society for Human Genetics, European Association for Cancer Research, Croatian Society for Neuroscience.

 Biography
Research Interest :

Cancer genetics, Wnt signaling pathway, brain tumorigenesis, tumor suppressor genes, oncogenes, genetic profiles of brain tumors, beta-catenin, axin, E-cadherin, APC, loss of heterozygosity, microsatellite instability, protein expression.

 Research Interest
 Network
Hong Zhang

Hong Zhang, MD, PhD
Associate Professor
Department of Biomedicine
University of Skövde
Sweden
Tel. 465-004-484-82/467-989-2882

Biography :

Hong Zhang is an Associate Professor in the Department of  Biomedicine
University of Skövde, Sweden.

 Biography
Research Interest :

1) Pathological features of oesophagus cancer. 2) Mechanisms behind cell damage by free radicals and repair. 3) Mechanisms behind chemotherapy in human skin melanoma. 4) Molecular mechanisms behind chemotherapy and radiotherapy in colorectal cancers; Biomarkers for early diagnosis, better therapy and patients survival in colorectal cancer.

 Research Interest
 Network
Miguel Lopez Lazaro

Miguel Lopez Lazaro, PhD
Associate Professor
Department of Pharmacology
University of Seville
Spain
Tel. 349-545-563-48
Fax 349-542-337-65

Biography :

Miguel Lopez Lazaro is an Associate Professor in the Department of Pharmacology at the University of Seville, Spain. Graduated in Pharmacy, he received a PhD in the Department of Pharmacology and completed a Marie Curie Postdoctoral Fellowship in the Department of Cell and Molecular Biosciences at the Medical School of the University of Newcastle, UK. In 1999, he became Associate Professor of Pharmacology at the University of Seville, where he currently holds a tenured position. His current areas of interest/expertise include several aspects of cancer biology and pharmacology (anticancer agents from natural origin, topoisomerase-mediated DNA damage, cancer metabolism, and role of oxidative stress in carcinogenesis and cancer therapy).

 Biography
Research Interest :

Anticancer agents from natural origin, Topoisomerase-mediated DNA damage, Role of oxidative stress in carcinogenesis and cancer therapy, Cancer metabolism, Theories of carcinogenesis.

 Research Interest
 Network
Thomas Wan

Thomas Wan, PhD
Associate Professor
Department of Pathology
University of Hong Kong
China

Biography :

Thomas Wan is currently the Cytogeneticist in charge and Honorary Associate Professor of the Department of Pathology, Queen Mary Hospital, University of Hong Kong, Hong Kong. He is also the Visiting Professor of the Fujian Medical University and Honorary Professor of the Harbin Medical University, China. Dr Wan was born in Hong Kong and obtained his Bachelor of Science in Medical Technology from the National Taiwan University, Taiwan in 1984. He obtained his Master of Philosophy and Doctor of Philosophy degrees at the University of Hong Kong in 1992 and 1997 respectively. Dr Wan is one of the most experienced cancer cytogeneticist in Hong Kong.  He is certainly the best qualified as well as the most prolific. Dr Wan has been awarded the Membership of the Royal College of Pathologists of the UK (specialized in Clinical Cytogenetics) based on published works in 2003. This achievement is no small feat and is one that is bestowed to basic and clinical scientists whose work is considered of the highest calibre.  He was awarded the Fellowship of the Royal College of Pathologists in 2008.  Dr Wan has been attached to several laboratories in the USA and Canada for research training, including Harvard Medical School, University of British Columbia, and the California Institute of Biological Research.  He has been chosen by Cold Spring Harbor Laboratory (USA) to attend advanced molecular cytogenetics courses. He is now considered one of the regional experts on molecular cytogenetics procedures.  He has frequently been invited to deliver lectures at academic institutions and scientific conferences in Asia. Dr Wan is the scientific advisor and consultant in many institutions and the HKSAR government. Furthermore, he serves in the editorial board of the International Journal of Oncology, Journal of the Association of Genetic Technologists, Atlas of Genetics and Cytogenetics in Oncology and Haematology. To date, he has authored more than 120 reports, reviews and on-line publications in international peer reviewed journals.

 Biography
Research Interest :

Study of hematological malignancies and pediatric solid tumours, especially on the genesis of the chromosomal aberrations in tumorogenesis.

 Research Interest
 Network
Prakash S Bisen

Prakash S Bisen, PhD
Chief
Research and Development
Tropilite Foods Pvt. Ltd
India

Biography :

Prakash S Bisen earned Ph.D. in 1972 and was awarded D.Sc in 1981 After his postdoctoral work, he joined as Assistant Professor at Jabalpur University and was elevated as Associate Professor. He then joined as Bhopal University as a Professor of Microbiology in 1985. Prof. Bisen was Visiting Professor at Institute of Environmental and Biological Sciences, University of Lancaster, Lancaster, England and Visiting Research Professor at the Department of Biological Sciences, The University of Illinois at Chicago, USA. He was U.S. National Science Foundation Fellow at University of California at Davis, USA in the Department of Bacteriology. Prof. Bisen was WHO/ UNESCO Fellow for One Year at Institute of Microbiology, Czechoslovak Academy of Sciences, Budejovika, Praha, Czechoslovakia; UNESCO/UNDP/ICRO and Hungarian Academy of Sciences Fellow at the Institute of Plant Physiology, Biological Research Center, Szeged, Hungary. He is honoured with Life time Professorship of Bundelkhand University, Jhansi, UP, India. He is also Honorary Professor of Biotechnology at Jiwaji University and is currently pursuing his research in the field of Medical Biotechnology as Emeritus Scientist at Defence Research and Development Establishment, DRDO, Ministry of Defence, Govt. Of India, Gwalior 474002, India.

 Biography
Research Interest :

Medical Biotechnology.

 Research Interest
 Network
Suresh Koduru

Suresh Koduru, PhD
Division of Immunology
Children’s Hosptial Boston
Harvard Medical School
USA
Tel: 617/919-2466

Biography :

Suresh Koduru is a Research Scientist at Children’s Hospital Boston, Harvard Medical School, Boston. He has received a PhD in Biochemistry from University of Hyderabad, Hyderabad, India. He has completed his M.S. in Biochemistry from S.V.University, Tirupathi, Inida. He received “Paul Doubler” award for excellence in studying Primary Immunodeficiency” in Human/Animal models. He has published 13 papers in peer-reviewed journals and he is serving as a member for Sigma Xi at Harvard Chapter.

 Biography
Research Interest :

Tumor Immunology, Transgenic animals models for inflammation and T cell trafficking. Use of monoclonal antibody therapy for human diseases.

 Research Interest
 Network
Benjamin J Daniel

Benjamin J Daniel, PhD
Department of Medicine
University of Texas
USA
Tel. (210) 567 3911

Biography :

Benjamin J Daniel is an Assistant Director- UTHSCSA Flow Cytometry Core – San Antonio,TX 2010 – Present Research Instructor -  UTHSCSA, Department of Medicine – San Antonio, TX Direct and Manage the Flow Cytometry core facility. Manage Day to day operation of flow cytometry core. Train personnel on use of the instruments and data analysis. Manage core accounting to ensure we are within our operating budget. Consult with users about design and execution of experiments pertaining to flow cytometry. Responsible to strategically plan and implement core goals in regards to, finance, equipment, core personnel. Write annual progress reports. Seek and execute external funding opportunities for new core instruments. Keep core website updated with technologies and flow cytometry methods. Implement billing procedures to ensure that the core is properly paid for services rendered. Operate core machines (FACSAria and FACSCalibur) as needed.

 Biography
Research Interest :

Cancer Biology.

 Research Interest
 Network
Sivakumar Vallabhapurapu

Sivakumar Vallabhapurapu, PhD
Department of Cancer and Cell Biology
University of Cincinnati
USA
Tel. 202-687-2347

Biography :

Sivakumar Vallabhapurapu completed his graduate training at the University of Karlsruhe, Karlsruhe, Germany, and was a postdoctoral fellow at the Fritz Lipmann Institute for Age Research in Jena, Germany and at the University of California, San Diego. At UCSD he worked with Dr. Michael Karin studying the regulation of NF-kB transcription factors in the immune system. In 2009, Siva joined the University of Cincinnati in the Department of cancer and cell biology.

 Biography
Research Interest :

Signaling pathways that regulate gene expression and control normal homeostasis and, when deregulated, lead to pathogenesis resulting in diseases such as cancer.

 Research Interest
 Network
Gregory S Yochum

Gregory S Yochum, PhD
Biochemistry and Molecular Biology
Pennsylvania State University
USA
Tel. 717-531-2091
Fax 717-531-7072

Biography :

Gregory S Yochum is an Assistant Professor of the Department of Biochemistry & Molecular Biology, Pennsylvania State University Hershey, PA, USA.

 Biography
Research Interest :

Deciphering the role of Wnt/ beta-catenin and mitogen regulation of c-Myc gene expression through a downstream DNA enhancer element.

 Research Interest
 Network
Mfon Samuel Cyrus-David

Mfon Samuel Cyrus-David, MS
Internal Medicine
The University of Texas Health Science Center
USA

Biography :

Mfon Samuel Cyrus-David  is a Principal Investigator, the University of Texas Medical School at Houston Cancer Bioinformatics Program (UTHealth-HMS CaBIP). The faculties of this program meet on a monthly basis to evaluate its progress, and plan for the future. The objectives of the UT Health-HMS CaBIP are to design, integrate, implement, operate and maintain cancer site-specific databases on all the types of cancers that are managed at the UT - Memorial Hermann Cancer Center, and the affiliated health establishments of the UT Medical School Houston, TX, such as the Memorial Hermann Hospital (MHH) at the TMC, and the Harris County Hospital District’s (HCHD) Lyndon B. Johnson General Hospital, Houston Texas, and its satellite health centers.

 Biography
Research Interest :

Cancer Biology.

 Research Interest
 Network
Noula D Shembade

Noula D Shembade, PhD
Microbiology and Immunology
University of Miami
USA
Tel. 305-243-7893
Fax 305-243-6410

Biography :

Noula D Shembade is an Assistant Professor of the Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami FL June 2008- June2009 Associate Scientist, Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami FL May, 2005- June 2008 Post-Doctoral Associate, Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL , USA.

 Biography
Research Interest :

Microbiology and Immunology.

 Research Interest
 Network
Dae Joon Kim

Dae Joon Kim, PhD
Department of Pharmacology
University of Texas
USA
Tel. 956-393-6411

Biography :

Dae Joon Kim is an Assistant Professor in the Department of Pharmacology, University of Texas, USA. Chair of Chemical Carcinogenesis Poster Session, The 48th Annual Meeting of Society of Toxicology, March 2009 2. Postdoctoral Representative for Dermal Toxicology Specialty Section, Society of Toxicology, 2008 - 2010. 3. American Association for Cancer Research, 2005 - present.  4. The American Society for Cell Biology, 2003 - present. 5. Society of Toxicology, 2002 - present.

 Biography
Research Interest :

Role of protein tyrosine phosphatases in skin homeostasis, toxicology, and carcinogenesis, Role of protein tyrosine phosphatases in the control of Stat3 signaling, Molecular signaling mechanisms of phosphatases in DNA damage repair.

 Research Interest
 Network
Shyamal Dilip Desai

Shyamal Dilip Desai, PhD
Department of Biochemistry and Molecular Biology
LSU Health Sciences Center
USA
Tel. (504) 568-4388
Fax (504) 568-3370

Biography :

Shyamal Desai is an Assistant Professor in the Department of Biochemistry and Molecular Biology at the Louisiana State University Health Sciences Center-School of Medicine, New Orleans, LA. Dr. Desai obtained her Bachelor of Science and Master of Science in Biochemistry from the University of Bombay, India in 1981 and 1983 respectively. She received her Doctorate in Biochemistry from the University of Bombay, India in 1991. Dr. Desai received New Jersey Cancer Research Award for Scientific Excellence in 1996 and 2003. She also received the American Association for Cancer Research-AFLAC Scholar Award in Cancer Research in 1999.  Dr. Desai is serving as an editorial board member of the Journal of Antivirals and Antiretrovirals and the Experimental Cell Biology and Medicine.

 Biography
Research Interest :

The role ubiquitin and ubiquitin-like protein ISG15 in cancer and neurodegeneration associated with the Ataxia Telangiectasia.

 Research Interest
 Network
Charles Kumar Thodeti

Charles Kumar Thodeti, PhD
Integrative Medical Sciences
Northeast Ohio Medical University
USA
Tel. (330) 325-6423
Fax (330) 325-5912

Biography :

Charles Kumar Thodeti is an Assistant Professor of Vascular Biology at Department of Integrative Medical Sciences, NEOUCOM(North Eastern Ohio Universities College of Medicine) Faculty, School of Biomedical Sciences, Kent State University, Ohio. He has received PhD in Zoology (Biochemistry &Physiology) from S.V. University, Tirupati, India, 1994. He has completed his M.S. in Zoology S.V. University, Tirupati, India, 1987. He is serving as an editorial board member of 1 journal and reviewer of 3 journals.

 Biography
Research Interest :

Mechanical Control of Endothelial Cell Function, Angiogenesis and Stem Cell Differentiation with focus on TRPV4 ion channels, Tumor angiogenesis and bone tissue engineering.

 Research Interest
 Network
Shenhong Wu

Shenhong Wu, MD, PhD
Hematology and Oncology
Stony Brook University
USA
Tel. (631) 444-2066

Biography :

Shenhong Wu is an Assistant Professor of Medicine, Stony Brook University Cancer Center, July 2006-present. Efficacy and serious adverse events of new anti-neoplastic treatment, particularly molecularly-targeted agents including sorafenib, sunitinib, and bevacizumab. Investigator-initiated trials under development: 1) Phase 1 study of targeted agents with chemotherapy. 2) Intra-carotid chemotherapy for newly diagnosed glioblastoma multiforme.Medical Oncology Branch, National Cancer Institute-Bethesda, MD.Clinical fellow, July, 2005- June, 2006. Clinical trials of prostate cancer using chemotherapeutic and targeted agents with Dr. William Dahut.University of Chicago - Chicago, IL. Research Associate, 1996 - 2001.Department of Pathology and Committee on Immunology, with Dr. Andrea J. Sant on the antigen processing and presentation to T lymphocytes by MHC class II molecules and DM regulation.Medical College of Wisconsin, Milwaukee, WI.Ph.D. Candidate, 1990 - 1996. Section of Immunogenetics, Blood Research Institute of the Blood Center of Southeastern Wisconsin, with Dr. Jack Gorski on the physiological and pathological antigen presentation by HLA molecules. Department of Pediatrics and Department of Cellular Biology, with Dr. Bahiru Gametchu on the mechanism of glucocorticoid-induced apoptosis mediated by glucocorticoid receptors in human leukemic cells. Shanghai Medical University, Shanghai, China, Resident, 1987-1990.

 Biography
Research Interest :

Targeted therapy, Clinical trials, Genito-urinary cancer and brain tumor,  Meta-analysis.

 Research Interest
 Network
Debanjan Chakraborty

Debanjan Chakraborty, Phd
Department of Pathology
The Ohio State University
USA
Tel. 614 2476361

Biography :

Debanjan Chakraborty is a Research Assistant Professor at Department of Pathology, Ohio State University. He has been Research Fellow at Chittaranjan National Cancer Institute, India which brought Dr. K.S. Krishnan Research Associateship, Govt. of India (2006)honorarium. Even he was a Research Fellow for Department of Biochemistry and Molecular Biology,Mayo Clinic (2006-2008). He is associated with American Association for Cancer Research, The American Physiological Society, National American Vascular Biology Organization presently. He serves as an Editorial Board Member for the Journal of Medical Sciences, International Journal of Pharmacology, International Journal of Cancer Research, Trends in Medical Research. He has 13 publication of research articles and presently granted with NIH support for research work on Dopamine as therapeutic agent in stomach cancer.

 Biography
Research Interest :

Tumor angiogenesis and metastasis, Peripheral vascular diseases

 Research Interest
 Network
Shi-Long Lu

Shi-Long Lu, MD, PhD
Otolaryngology, Dermatology and Pathology
University of Colorado
USA
Tel. (303) 724 3074

Biography :

Shi-Long Lu is an Assistant Professor in the Departments of Otolaryngology, Dermatology and Pathology, University of Colorado,USA.

 Biography
Research Interest :

Cancer Research, Oncogene, Clinical Cancer Research, Molecular Carcinogenesis, Molecular Cancer Therapeutics.

 Research Interest
 Network
Sung-O Kim

Sung-O Kim, PhD
Electrical and Computer Engineering
Clemson University
USA
Tel. 864-656-5907
Fax 864-656-5910

Biography :

Sung-O Kim is currently Assistant Professor at the Holcombe Department of Electrical and Computer Engineering in Clemson University. His expertise is in flat panel displays (Liquid Crystal Displays, Plasma Display Panels, Organic Lighting Emitting Displays, and Flexible Displays), micro and nano-plasma devices, micro and nano-bio fuel cells, and various thin films. He earned B.S. in Electrical Engineering at Howon University, Korea. He received his M.S. and Ph.D in Electrical Engineering at Inha University in Korea where his thesis on advanced lithography using plasma polymerization received presidential award at Inha University. Dr. Kim has served at the Department of Photonics and the Display Institute as a faculty in National Chiao Tung University (NCTU), Taiwan from 2004 to 2008. Prior to joining NCTU, he was a Postdoctoral Research Fellow (2001-2004) in University of Illinois at Urbana-Champaign (UIUC). At UIUC, he worked on the development of micro-plasma and plasma display panel. Prior to joining UIUC, he worked for Samsung SDI as a Technical manager and R&D Engineer (2000-2001). At Samsung SDI, he researched the plasma and thin films in plasma display panel. Dr. Kim also served an assistant professor (1998-2000) at Howon University in Korea. Sung-O Kim is a member of Society of Information Display, American Vacuum Society, American Physical Society, The Korean Information Display Society, The Korean Institute of Electrical Engineers, The Korean Institute of Illuminating and Electrical Installation Engineers, and The Korean Institute of Electrical and Electronic Material Engineers.

 Biography
Research Interest :

Flat Panel Displays: Development and applications of electronic displays such as liquid crystal displays, plasma display panels, OLED, flexible displays. Micro and Nano Plasma devices: Nano and micro plasma devices consist of structures fabricated on silicon, ceramic, or glass substrates that are used to confine weakly ionized plasmas. The diameters of the nano and microdischarge devices currently being fabricated range from several hundred microns down to tens of nano. Developing nano and microdischarge devices to investigate their physics, optical, and Electrical properties.Micro and Nano-Bio Fuel Cells: Develop micro or nano scale bio fuel cells to use fuel cell’s techniques and silicon processes.Plasma Thin Films: The properties of plasma polymerized thin films can be used for many applications such as low k materials in semiconductor devices and completely hydrophobic thin films. In addition to environmental applications, these films can be used in semiconductor, electrical, optical, and magnetic devices and flat panel displays.

 Research Interest
 Network
Xiangshu Xiao

Xiangshu Xiao, PhD
Physiology and Pharmacology
Oregon Health & Science University
USA
Tel. (503) 494-4748

Biography :

Xiangshu Xiao is an Assistant Professor in the Department of Physiology
and Pharmacology, Oregon Health & Science University, Portland, OR, USA. Journal Reviewer: Journal of the American Chemical Society, Journal of Organic Chemistry, ACS Chemical Biology, Journal of Molecular Structure: THEOCHEM, Bioorganic & Medicinal Chemistry Letters, Protein & Peptide Letters Grant Reviewer: Alzheimer’s Association (2008, 2009, 2010), Maryland Industrial Partnerships program (2009, 2010).

 Biography
Research Interest :

Chemical biology, Cancer.

 Research Interest
 Network
Yunzhi Yang

Yunzhi Yang (Peter), PhD
Restorative Dentistry and Biomaterials
The University of Texas
USA
Tel. 713-486-4136

Biography :

Yunzhi Yang (Peter) is an Assistant Professor of the Department of Restorative Dentistry and Biomaterials, The University of Texas, Texas, USA. Representative for advocating for the public awareness of biomedical research and introduction of my research for wounded soldiers to the Health Subcommittee, the Veteran Affairs at Capitol Hill on March 4, 2010, sponsored by the American Institute of Medical and Biological Engineering Representative for advocating for biomedical research and the increase in NIH funding to Senators and Congressmen offices at Capitol Hill on Feb 24, 2010, sponsored by the American Institute of Medical and Biological Engineering Invited presentation in Congressional Briefing on translational research breakthroughs at Capitol Hill on Feb 24, 2010, Sponsored by the American Institute of Medical and Biological Engineering Invited presentation in the annual conference of the American Institute of Medical and Biological Engineering at Washington DC on Feb 23, 2010 .

 Biography
Research Interest :

Designing and developing bio-inspired biomaterials for implant devices, tissue regeneration, and cancer treatment. Our research lies at the interfaces of fundamental material science, biology, clinical applications at the macro-, micro- and nano- scale level, where basic understanding of biology inspires the development of novel biomaterials for medical applications. We believe quality work depends on idea, passion and perseverance. The students and postdoc fellows who join our group will have opportunities to learn from and work with engineers, biologists and clinicians.

 Research Interest
 Network
Arutselvan Natarajan

Arutselvan Natarajan, PhD
Department of Radiology/Molecular Imaging
Stanford University
USA
Tel. 650-736-9822
Fax 650-724-4948

Biography :

Arutselvan Natarajan is an Instructor, Molecular Imaging Program at Stanford, Department of Radiology, School of Medicine, Stanford University. Assistant Research Professor, Radiodiagnosis and Therapy Section, Internal Medicine, School of Medicine, University of California Davis (2005-2009). Advance Postdoctoral Fellow, Radiodiagnosis and Therapy Section, Internal Medicine, School of Medicine, University of California Davis (2002-2005). PhD in Industrial Chemistry at Alagappa University, India (2000). MS., in Pharmaceutical and Biochemistry (1990). B.Sc., in Chemistry in Madras University, India, NY (1982). Number of publications and book chapters 40, Conference Presentations: 60. Reviewer for peer reviewed scientific journals: Cancer Biotherapy and Radiopharmaceuticals, Bioconjugate Chemistry, Langmuir, ACS Nano and Molecules.

 Biography
Research Interest :

Molecular Cancer Diagnosis, Imaging and Therapy, Chemistry, Proteins, Antibodies, Antibody Fragments, Small molecules, Peptides, Antioxidants, Lipids, Phytochemicals, Carbohydrates, Nutraceuticals and Pharmaceuticals, PEGylation and PEG technology, Radiochemistry, PET and SPECT, Biological Chemistry, Gene transfer using siRNA, and miRNA for imaging and therapy, Reagents for Early Diagnosis of Cancer, Nanotechnology, Drug delivery using Electroporation and vectors of Fullerene, Iron oxide, Gold Nanoparticles and Immunoparticles, Clinical Research, Clinical Translational Research for Cancer, FDA regulations, Investigational New Drugs, GLP and GMP.

 Research Interest
 Network
Sreenivasa R Chinni

Sreenivasa R Chinni, PhD
Urology and Pathology
Wayne State University
USA
Tel. 313-577-1833/313-577-1832
Fax 313-577-0057

Biography :

Sreenivasa R Chinni is an Associate Professor in the Department of Urology and Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University, USA.

 Biography
Research Interest :

Prostate cancer, chromosomal alterations, chemokine and chemokine receptors, and cell signaling and metastasis. Molecular mechanism of prostate cancer metastasis. Currently, the Chinni laboratory is studying the role of chemokines and chemokine receptors in tumor cell invasion and metastasis using in vitro and in vivo preclinical models of metastasis. Dr. Chinni recently found that chemokine receptor CXCR4 highly localizes to lipid rich membrane microdomains, activate members of growth factor family receptors and down stream signaling pathways. In tumor cells this transactivation pathway further contributes to intraosseous tumor growth of prostate cancer cells. Other project in the lab is to define molecular targets of recently identified recurrent chromosomal alterations in prostate cancer patients. The Chinni laboratory subsequently identified that androgen activation of common chromosomal translocations, TMPRSS2-ERG induce CXCR4 transcription, and thereby contributing to enhanced invasion and metastasis of prostate cancer cells. Dr. Chinni and colleagues are currently characterizing the functional significance of chromosomal translocations and chemokine receptor expression in prostate cancer metastasis.

 Research Interest
 Network
Benny Abraham Kaipparettu

Benny Abraham Kaipparettu, PhD
Molecular and Human Genetics
Baylor College of Medicine
USA
Tel. 713-798-5469

Biography :

Benny Abraham Kaipparettu major research interest of Dr. Kaipparettu is in breast cancer stem cells (His publications before 2006 was with the name Abraham BK due to official name change). After bachelor and master degree in pharmacy, Dr. Kaipparettu continued his career in pharmacogenomics and obtained PhD in Pharmacology for his research in CYP2D6 polymorphism. During his first postdoctoral fellowship in Germany, Dr. Kaipparettu focused on pharmacogenomics in breast cancer. In 2003 when initial reports about putative breast cancer stem cells (BCSCs) published, he investigated its clinical significance in breast tumors and published one of the first studies on the clinical significance of BCSCs. His observations suggested the relevance of BCSCs in distant metastasis. The findings in his publication were further verified by several other research groups and extensively cited in other cancer stem cell publications. Later he moved to Baylor College of Medicine, Houston, USA and continued his work on the regulation of cancer stem cell markers by hormone receptors and its epigenetic silencing. Mean time, he also focused on the higher order regulation of clustered genes by scaffold proteins and the development of economic technologies for three dimensional (3D) cell culture. In 2009 Dr Kaipparettu was promoted as a Junior Faculty in Baylor College of Medicine and in 2010 he has became an Assistant Professor in the Department of Molecular and Human Genetics, Baylor College of Medicine.

 Biography
Research Interest :

Tumour initiating cells, Mitochondrial Nuclear Cross talk in Cancer, Cancer epigenetics,  Pharmacogenomics, Epigenetics and energy regulation in breast tumor initiating cells.

 Research Interest
 Network
Samy L Habib

Samy L Habib, PhD
Department of Medicine
The University of Texas Health Science Center
USA
Tel. 210-567-4699
Fax 210-567-4712

Biography :

Samy L Habib is an Assistant Professor of the Department of Medicine, The University of Texas, Health Science Center, San Antonio, TX, USA and has strong background in molecular carcinogenesis, with specific training and expertise in several research areas. He was a co-Investigator on several previous and current projects funded by ADA, NKF, AHA, VA and NIH. Attesting to his national visibility,he has been selected to serve as a regular reviewer for the Medical Research Program of the Department of Defense and Editorial Board Member of 2 Journals.

 Biography
Research Interest :

Carcinogenesis in diabetes, Mutations in DNA repair gene in diabetes and cancer,  Role of Tuberin in Neuronal Degeneration,  Role of Tuberin in Renal Hypertrophy and Fibrosis, Role of Tuberin in Tumorigenesis, Role of tuberin/mTOR pathway in apoptosis. (1) Understanding the role of oxidant stress in the pathogenesis of renal cell carcinoma (2) Screening cancer and diabetic patients for DNA repair gene mutation(s), (3) Explore the mechanism of renal hypertrophy and fibrosis in diabetic patients, (4) Study the mechanism by which TSC2 gene regulates the DNA damage (8-oxodG) and repair (OGG1) pathways and other signal transduction including cell cycle proteins in the pathogenesis of renal carcinogenesis, (5) study the role of tuberin/mTOR pathway in apoptosis in diabetes, (6) Study the role of tuberin/mTOR pathway in the regulation of the neuronal damage in Alzheimers diseases (AD) and Parkinson diseases.

 Research Interest
 Network
Dakshanamurthy Sivanesan

Dakshanamurthy Sivanesan, PhD
Assistant Professor of Oncology
Clinical & Experimental Drug Discovery Program
Georgetown University Medical Center
USA
Tel. 202-687-2347

Biography :

Dakshanamurthy Sivanesan is an Editorial Board Member, International Journal of Nanomaterials and Technology Editorial Board Peer Review Member, Dove Press Journals Susen Komen Foundation Study Section Advisory Board Member “Scientific Journals International” Scholarship of National Biomedical Computational Resource Summer Institute, Aug. 2006, San Diego, CA USA. Reviewer to Bioorganic Medicinal Chemistry Letters, Bioorganic Medicinal Chemistry, Journal of Molecular Biology, Journal Chemical information & computer science, Journal of molecular Cancer Therapeutics, Journal of American Chemical Society, Cancer Informatics, Journal of Molecular Graphics & Modeling, Knowledge Generation, Communication and Management.Biography published in the 8th edition of Marquis Who’s Who in science and Engineering, December 2004. MEXT Fellowship (Special coordination for Promoting Science & Technology) JAPAN Travel Award from Department of Science & Technology (DST), Government of India to attend international conference held in FRANCE. Travel Award from Tamil Nadu Science & Technology, Government of India to attend International conference held in FRANCE. Jawaharlal Nehru Science Talent Outstanding Student, State Government, INDIA Scholarship for higher studies in Russia, by Patrice Lumumba Peoples Friendship University sponsored by Russian Government and ISCUS, India.

 Biography
Research Interest :

Structure based drug discovery, Ligand based drug discovery, Homology modeling, Molecular Dynamics & Molecular Mechanics, Simulations, Protein modeling, Bioinformatics, Quantum chemistry, Biochemistry, Molecular Biology, Physics, Chemistry.

 Research Interest
 Network
Manjeet Rao

Manjeet Rao, PhD
Cellular and Structural Biology
The University of Texas Health Science Center
USA
Tel. 210-562-9119

Biography :

Manjeet Rao joined the Greehey Children’s Cancer Research Institute in January of 2007 with major faculty responsibilities as a Principal Investigator in Molecular Oncogenesis and Assistant Professor in the Department of Cellular and Structural Biology. Dr. Rao attended the University of Delhi, India and received his Ph.D from the University of Delhi, India. He completed his post-doctoral research at The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA. Dr. Rao is a molecular biologist who studies the role of small regulatory RNAs in cancer growth and progression. In collaboration with other PIs at GCCRI, he is investigating the role of naturally occurring short RNA- “micro RNA” in different types of pediatric cancers including Wilms’ tumor. For his research on tissue-specific RNAi, Dr. Rao has been supported by the National Institutes of Health.

 Biography
Research Interest :

Function and regulation of an imprinted homeobox gene that encodes for a potent tumor antigen. By using Rhox5 as a model system he addressed the mechanism by which a tissue-specific gene can be corrupted in tumors. In addition, he developed a novel tissue-specific in vivo RNA interference (RNAi) approach that can be used to silence virtually any gene in the genome. As a proof of principle he used this approach to study the after birth function of WT1 tumor suppressor gene that if mutated in humans increases the probability of acquiring childhood kidney tumors, leukemia, and other types of cancer.

 Research Interest
 Network
Kamalesh Kumar Sankhala

Kamalesh Kumar Sankhala, MD
Division of Hematology & Oncology
The University of Texas
USA
Tel. 210-450-5956/210-667-7029

Biography :

Kamalesh Sankhala has received his medical degree (MD) and residency training in Internal Medicine from University of Rajasthan, India and Fellowship in Medical Oncology from University of Texas Health Science Center San Antonio, Texas. Currently he is working as a clinical investigator at the Institute for Drug Development (IDD), Cancer Therapy and Research Center of The University of Texas Health Science Center at San Antonio. Since 2003. Dr. Sankhala has been working in the area of Oncology Drug Development Research. IDD is known for being the largest Oncology drug development research program in the United States and has set unprecedented standards for the development of novel anti-cancer agents, playing a key role in the preclinical and clinical development of 20 new cancer drugs that were subsequently approved by the Food and Drug Administration (FDA). Since he joined IDD in 2006, Dr. Sankhala has worked as clinical investigator on about 22 investigational clinical studies on novel anti-cancer drugs; additionally he has been a sub-investigator on 80 other clinical studies. He is the recipient of American Society of Clinical Oncology Foundation Merit Award and AACR-NCI scholarship for Molecular Biology in Clinical Oncology. He has authored several research articles and is a reviewer of reputed Journals in the field of oncology.

 Biography
Research Interest :

Translational research of novel anti-cancer agents and on studying the pre-clinical and clinical aspect of these agents. His clinical experties include management of patients with Sarcoma, head & neck and gynecology cancers.

 Research Interest
 Network
Fabricio F Costa

Fabricio F Costa, PhD
Cancer Biology and Epigenomics Program
Northwestern University
USA
Tel. (857) 753 7136

Biography :

Fabricio F Costa has obtained his PhD in the worldwide renowned Ludwig Institute for Cancer Research. He has completed his training for two years at the Massachusetts General Hospital, affiliated with Harvard University in Boston,MA. He works now as a research scientist at Children’s Memorial Research Center and Northwestern University in Chicago, IL. He has published several peer-reviewed articles in the cancer research, genomics and epigenomics fields and has worked as a consultant for newspapers in the biotech sector. He has also given interviews to the scientific journal ""Nature Biotechnology"" and to the british magazine ""The Economist"" about his work. Dr Costa was also a reviewer for ~30 articles from different journals, currently work as a consultant for two research groups in Brazil in the epigenetics field (one in Sao Paulo and the other in Curitiba) and has also evaluated projects for the “Bando Giovani” or “Young Investigator Award” promoted by the Italian Ministry of Health in Italy and for the “Cancer Research UK” Funding Agency in England. Dr Costa’s work was recently featured in the cover of the Bioessays journal in a review article that discusses the emergence of non-coding RNAs (ncRNAs) as important players in the epigenomics field.

 Biography
Research Interest :

Oncology/Cancer,  Neurology/Molecular, Neurogenetics and Cancer biology.

 Research Interest
 Network
Prakash Radhakrishnan

Prakash Radhakrishnan, PhD
Eppley Cancer Center
University of Nebraska Medical Center
USA
Tel. 402-559-4027

Biography :

Prakash Radhakrishnan completed his undergraduate B.Sc in Biochemistry at Bharathidasan University (1996-99), Trichy, India, and M.Sc. in Molecular biology (1999-01) and Ph.D. in Molecular biology (2001-06) from University of Madras, Chennai, India. He was a Post-doctoral Research Associate in the Department of Biochemistry and Molecular biology (2005-08), University of Nebraska Medical Center, Omaha, NE, USA. Currently, working as a Research Associate at Eppley Cancer Institute, University of Nebraska Medical Center, Omaha, NE, USA. Received Junior Research Fellowship award from Indian Council of Medical Research (ICMR) and Senior Research Fellowship from Council of Scientific and Industrial Research (CSIR) during his graduation. Recipient of Postdoctoral Research Fellowship award from Department of Defense (CDMRP), Federal government of USA. He is serving as a Grant Reviewer for National University of Singapore and Reviewer for journals in Springer link publications and science-alert peer review system.

 Biography
Research Interest :

Role of mucins in inflammatory diseases, Role of mucins and mucin-glycans in cancer progression and metastasis, (Including prostate and Pancreatic cancer), Gene silencing by Promoter methylation.

 Research Interest
 Network
Xichun (Mark) Zhou

Xichun (Mark) Zhou, PhD
ADA Technologies
USA
Tel. (303) 874-8273/(303)-717- 4518
Fax (303) 792-5633

Biography :

Dr. Xichun Zhou received his Ph.D. degree in organic and bioanalytical chemistry at Wuhan University (1994) and had postdoctoral training in the Department of Chemistry, Carmbridge University, UK. He has been a Senior Research Scientist at ADA since 2005, where he leads a program in glycomics and development of biotechnology and biochemical devices. Prior to joining ADA, he was a Research Scientist at Oak Ridge National Laboratory where he led projects on surface chemistries associated with nanoengineered interface of DNA, proteins and carbohydrates for microarray/biochips and biosensor application. Dr. Zhou had a joint appointment with the Graduate School of Genome and Technology at the University of Tennessee during year 2003-2005, where he managed and conducted a project for development of microarray technology. Dr. Zhou has authored twenty peer-reviewed papers, three invited book chapters, and two US Patents in protein microarray and glycomic technology. He has served for NIH study sections in Special Emphasis Panel in 2007.

 Biography
Research Interest :

Cancer Science.

 Research Interest
 Network
Hareesh B B Nair

Hareesh B B Nair, PhD
Department of Genetics
Southwest National Primate Research Center
USA

Biography :

Hareesh B B Nair did B.S (1996) in  Biological Sciences at Mahatma Gandhi University, India  M.S (1998) in  Biological Sciences at University of Kerala, India. Ph.D. (2003) in Biochemistry at Mahatma Gandhi University, India. Dr. Nair is Assistant Professor at the University of Texas Health Sciences Center in San Antonio of the Department of Obstetrics and Gynecology.

 Biography
Research Interest :

Understanding the basic biology of breast cancer developing novel therapeutic approaches.

 Research Interest
 Network
Mei-Sze Chua

Mei-Sze Chua,  PhD  
Department of Surgery/General Surgery
Stanford University
USA

Biography :

Mei-Sze Chua is a Senior Research Scientist at the Asian Liver Center, and Department of Surgery at Stanford University School of Medicine, California, USA. She received her Ph.D. in Pharmaceutical Sciences from the School of Pharmacy, University of Nottingham, England. Before that, she graduated with First Class Honors from the Department of Pharmacy, National University of Singapore, Singapore. She is a Guest Editor of a Hot-Topic Special Issue in Anti-Cancer Agents in Medicinal Chemistry; an editorial board member of two reputed journals and a reviewer of multiple internationally respected journals, such as Cancer Research, Cancer Letters, European Journal of Cancer, Molecular Cancer Therapeutics, Gastroenterology, Hepatology, Journal of Hepatology, and Journal of Pathology. She also has 24 publications in peer-reviewed journals, including the New England Journal of Medicine, Cancer Research, International Journal of Cancer, and Journal of Medicinal Chemistry.

 Biography
Research Interest :

Experimental therapeutics, Cancer diagnostic and prognostic markers, Therapeutic targets for hepatocellular carcinoma, Novel strategies for imaging hepatocellular carcinoma, Cancer genomics, Functional and chemical genomics.

 Research Interest
 Network
Sanjeev K Baniwal

Sanjeev K Baniwal, PhD
Department of Orthopaedics
University of Southern California
USA
Tel. (323)-442-3914
Fax (323)-442-2764

Biography :

Sanjeev K Baniwal received PhD degree in molecular cell biology from Goethe University, Germany in 2007. Current focus of his lab at the University of Southern California (USC) is to understand the molecular basis of interaction between steroid hormone receptors and Runx2. Since these transcription factors perform major regulatory roles in tumor and skeleton biology, Dr Baniwal’s work has important implications not only for Prostate and Breast cancers but also to osteoporosis and other skeletal metabolism related disorders.

 Biography
Research Interest :

Transcriptional control of gene expression, Prostate cancer, Breast cancer, Osteoporosis.

 Research Interest
 Network
Rajendra Kumar Singh

Rajendra Kumar Singh, PhD
Health and Environmental Sciences
Dow Corning Corporation
USA
Tel. 305-243-1017/786-493-0449

Biography :

Rajendra Kumar Singh is a  Senior Toxicologist at Dow Corning Corporation Health and Environmental Sciences, USA.

 Biography
Research Interest :

Cancer Science.

 Research Interest
 Network
Junqiang Tian

Junqiang Tian, PhD, MD
Radiation and Oncology
Stanford University
USA
Tel. (650)-580-3390

Biography :

Junqiang Tian  is currently a Postdoctoral scholar at Urology Department in Stanford University. He received his Ph.D. in Nutrition and Health Sciences in Emory University, Atlanta, GA in 2002-2006; and his M.D. in Clinical Medicine in Shanghai Medical University, Shanghai, P.R.C. in 1986-1992. He has received Young Investigator Travel Awards from International Congress of Radiation Research (ICRR, 2007) and Postdoctoral Fellowship from American Urological Association (2008-2010). He has published over 10 peer-reviewed articles and has served as an ad hoc reviewer in Cancer Biotherapy and Radiopharmaceuticals and Clinical Lymphoma and Myeloma.

 Biography
Research Interest :

Developing redox-active chemotherapeutic agents and radiation sensitizers for cancer treatment. These agents attack cancer cells with disturbed redox millieu and thus more susceptible to cell death induced by redox imbalance. Many of the agents under investigation are micronutrients that are present and can be supplemented in food, such as ascorbic acid and selenium compounds, thus his research provide potential nutritional approaches of cancer treatment.

 Research Interest
 Network
Feng Jiang

Feng Jiang, MD, PhD
Department of Pathology
University of Maryland
USA
Tel. (410) 706-4854
Fax (410) 706-8414

Biography :

Feng Jiang research has focused upon understanding molecular genetics aberrations and translating the resultant discoveries into clinical application for enhancing diagnosis and therapy of human malignancies. In the MCRCDP program. Dr. Jiang proposed to develop a noninvasive genetic test using an optimal panel of biomarkers for predicting recurrence of stage I lung cancer after surgery. There are three specific aims: 1) identify an optimal panel of genetic signatures that can be detected in sputum for accurately predicting lung cancer recurrence in an existing cohort of recurrent and nonrecurrent stage I lung cancer patients, 2) develop the genetic signatures as a robust and objective diagnostic test by labeling the genetic probes with quantum dots and counting signals with automation of fluorescent dot-counting, 3) prospectively validate the new diagnostic test for predicting recurrence in an independent cohort of stage I lung cancer patients by correlating the results with their clinical outcomes. The study will form the foundation for future multiple-center clinical trails designed to rapidly and widely adopt this prognostic approach in routine clinical practice. Its application in clinical settings will identify the patients at high risk for recurrence, potentially lead to more personalized treatment, and ultimately reduces lung cancer mortality.

 Biography
Research Interest :

To understand genomic and genetic aberrations lead to tumor formation, identify cancer genes, and translate the resultant new technologies and information into clinic for diagnosis and therapeutic interventions of cancer.

 Research Interest
 Network
Srinivas Odde

Srinivas Odde, PhD, MRSc
Pharmacology and Pharmaceutical Sciences
University of Southern California
USA
Tel. (323) 442-3979

Biography :

Srinivas Odde has been working in the Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, USA.

 Biography
Research Interest :

Cancer Science.

 Research Interest
 Network
Ranxin Shi

Ranxin Shi, PhD
Apoptosis and Cell Death Program
Burnham Institute for Medical Research
USA

Biography :

Ranxin Shi is a Postdoctoral research fellow at Sanford-Burnham Medical Research Institute, La Jolla, CA. He received a Ph.D degree in molecular and cell biology at National University of Singapore, in Singapore 2006. He received a Young Scientist Award of National University of Singapore-National Medical Research Council (NUS-NMRC) in Singapore 2005. He has been a member of American Association for Cancer Research (AACR) since 2007. He is serving as a reviewer for 6 scientific journals. He has 1 patent, 1 book chapter and 11 scientific publications.

 Biography
Research Interest :

Mechanisms of Apoptosis, Mechanisms of Inflammation , High Throughput Screening and Drug Discovery, Inflammation or Apoptosis-targeted Drug Discovery, Mechanism of anti-cancer and Anti-inflammation drugs.

 Research Interest
 Network
Bryan Smith

Bryan Smith, PhD
Molecular Imaging
Stanford University
USA

Biography :

Bryan Smith is a Stanford Deans Fellow, Stanford University (2007), NIH Post-doctoral Award -- Stanford Molecular Imaging Scholar, NIH (2006-2010), National Science Foundation Graduate Fellowship, IGERT, NSF (2003-2006).

 Biography
Research Interest :

Radiology and Cancer.

 Research Interest
 Network
Taranjit Gujral

Taranjit Gujral, PhD
Chemistry and Chemical Biology
Harvard University
USA
Tel. (617) 417-7278

Biography :

Taran Gujral is a Research Fellow at Department of Chemistry & Chemical Biology, Harvard University, Cambridge, MA. He has received a PhD in Pathology & Molecular Medicine from Queen’s University, Kingston, Canada in, 2008. He has completed his B.Sc (Hon) in Life Sciences and Mathematics from Queen’s University, Kingston, Canada (2003). He is serving as an editorial board member of reputed journals and reviewer of 5 journals.

 Biography
Research Interest :

Tumor and Stem Cell Biology, Signal Transduction and Miniaturized Proteomic Technologies.

 Research Interest
 Network
Zhen Cheng

Zhen Cheng, PhD
Molecular Imaging Program
Stanford University
USA
Tel. 650-723-7866
Fax 650-736-7925

Biography :

www.omicsonline.org/scholarly/cancer-science-journals-articles-ppts-list.phpZhen Cheng is an Assistant Professor of Radiology and a member of the Molecular Imaging Program at Stanford (MIPS), BioX program, Canary Center at Stanford for Cancer Early Detection and Stanford Cancer Center. He received his PhD in Chemistry from the University of Missouri-Columbia and completed his post-doc at Harvard Medical School. Dr. Cheng has published over 60 peer reviewed articles. He has served as reviewers for several funding agencies including National Institute of Health (NIH), Department of Defense (DOD) and Department of Energy (DOE). He is also actively serving as a reviewer for over 30 journals and an editorial board member of three journals. Dr. Cheng received Young Investigator Award form Melanoma Research Alliance, New Instigator Award from DOD, and 2009 Best Basic Science Paper from Journal of Nuclear Medicine. Dr. Cheng is currently the head of the Cancer Molecular Imaging Chemistry Laboratory of MIPS where he is developing novel molecular imaging probes, non-invasive imaging techniques and bionanotechnology for the early detection and treatment of cancer.

 Biography
Research Interest :

Molecular Imaging and Cancer.

 Research Interest
 Network
Dan Crichton

Dan Crichton, MS
Jet Propulsion Laboratory (JPL)
USA
Tel. (818) 354-9155
Fax (818) 393-3405

Biography :

Dan Crichton is working in Jet Propulsion Laboratory (JPL), JPL/Caltech, Pasadena, CA, USA.

 Biography
Research Interest :

Informatics.

 Research Interest
 Network
Neelu Puri

Neelu Puri, Phd 
Department of Biomedical Sciences
College of Medicine
University of Illinois
USA
Tel. (815) 395-5678
Fax (815) 395-5666

Biography :

Dr. Neelu Puri has received his PhD All India Institute of Medical Sciences during the period of 1989. Currently, she is working as Assistant Professor in University of Illinois. She has successfully completed his Administrative responsibilities as Scientist, Post Doc, Research Associate, and Assistant Researcher. She is serving as an Ad hoc Reviewer of several reputed journals like Journal Molecular Cancer Therapeutics, Oligonucleotides, Cell Communication Insights, Neoplasia, Life Sciences, and Therapeutic Advances in Medical Oncology. She has authored 28 research articles and 1book. She is a member of American Association of Cancer Research, American Gastroenterological Association, and American Medical Writers Association. She has honoured as Faculty Support Scholarship Award, University of Illinois College of Medicine at Rockford, Rockford, IL, USA, 2012. Awarded with many grants like UIC Cancer Center Pilot grant, NIH R21, NIH R01 grant.

 Biography
Research Interest :

Cancer research, Molecular Biology, Biochemistry, and Cell Biology,Therapeutic target, senescence and Apoptosis in cancer cells

 Research Interest
 Network
Michael Danquah

Michael Danquah
Department of Pharmaceutical Sciences
Chicago State University
USA
Tel. (773) 821-2167
Read Interview session with Michael Danquah

Biography :

Michael Danquah, M.S., Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College ofPharmacy (CSU-COP). He obtained his Master’s Degree in Chemical Engineering from the University of Kentucky, and aPh.D. in Pharmaceutics and Drug Delivery from the University of Tennessee Health Science Center. He has several peer-reviewed journal articlesand is the author of the book “Emerging Trends in Cell and Gene Therapy”.

 Biography
Research Interest :

• Design and synthesis of novel biodegradable polymers for controlled drug and nucleic acid delivery

• Nano based combination therapy for treating cancer

• Design and construction of novel bipartite shRNA expressing plasmids for cancer therapy

• Formulation, delivery, in vitro and in vivo characterization of siRNA,shRNAand miRNAsfor treating cancer

• Application of stem cells and biomaterials for tissue regeneration and repair

 Research Interest
 Network
Mukesh K. Pandey

Mukesh K. Pandey
Department of Radiology
Mayo Clinic
USA

Biography :

Dr Mukesh K Pandey has received his PhD in Synthetic Organic and Natural Product Chemistry from the University of Delhi, during the period of 2000-2005. Currently, he is working as an Assistant Professor of Radiology at Mayo Clinic Rochester MN USA. He is serving as an editorial member of reputed journals like American Journal of Nuclear Medicine and Molecular imaging and the Journal of Cancer Science and Therapy. He has authored twenty-nine research articles/book chapters. He is a member of the Royal Society of Chemistry London and the American Chemical Society. He holds a designatory title of MRSC honored by the Royal Society of Chemistry London. He is one of the recipients of the Radiology advanced award from the Mayo Clinic Rochester MN in the year 2012.

 Biography
Research Interest :

Research interest lies in design and development of new PET molecular imaging probes for the diagnosis of neurodegenerative diseases and hypoxic cancers.

 Research Interest
 Network
Binoj Chandrasekharan Nair

Binoj Chandrasekharan Nair, Phd
Experimental Radiation Oncology
MD Anderson Cancer Center
USA
Tel. 210-912-3729

Biography :

Binoj Chandrasekharan Nair is currently a postdoctoral researcher at UT MD Anderson Cancer Center, Houston. He has received his BVSc &AH degree from Kerala Agricultural University (2002), Masters in Veterinary Pathology from Indian Veterinary Research Institute (2005) and PhD from University of Texas Health Science Center, San Antonio ,Texas(2011)

 Biography
Research Interest :

Gynecologic cancer, Endocrinology, Molecular Biology, Radiation and DNA damage response, Identification of novel molecular targets and pathways for therapeutics, Tumor markers of diagnostic/prognostic significance, Preclinical drug testing and in vivo mice models (xenograft/transgenic/knockout mice models).

 Research Interest
 Network
Behjatolah Monzavi-Karbassi

Behjatolah Monzavi-Karbassi
Department of Pathology
University of Arkansas for Medical Sciences
USA
Tel. 501-526-7874
Fax 501-526-5934
Read Interview session with Behjatolah Monzavi-Karbassi

Biography :

Dr. Monzavi-Karbassi is an Assistant Professor in the Department of Pathology at University of Arkansas for Medical Sciences, Little Rock, AR, USA. Dr. Karbassi received his Ph.D. in Molecular Biology from Institute of Molecular genetics, Russian Academy of Sciences, Moscow, Russia in 1997. He then did a postdoctoral training in Immunology and tumor biology at the University of Pennsylvania, Philadelphia, PA, USA from 1998 to 2002. He has published more than 40 research articles and earneda broad national and international recognition in his field. He has beenserving as a reviewer for several cancer-related journals and on multiple grant review panels.

 Biography
Research Interest :

Breast cancer. Tumor glycobiology and role of tumor-associated glycans in tumor progression and metastasis. Chondroitin sulfate glycosaminoglycans as biomarkers and therapeutic targets. Tumor immunology and immunotherapy. Tumor vaccine targeting tumor associated carbohydrate antigens.

 Research Interest
 Network
Rachana Garg

Rachana Garg
School of Medicine
University of Pennsylvania
USA
Tel. 1-267- 994-8611

Biography :

My interest in cancer research started when I undertook a dissertation project during my undergraduate studies at the Division of Molecular Oncology, Institute of Cytology and Preventive Oncology (ICPO), under the guidance of Dr. B.C. Das (Founder Director of ICPO, India). This research was focused on dissecting the relationship between human papilloma virus and AP-1 transcription factor in the development of oral cancer. I had the opportunity to work with biopsy tissue specimens from patients with oral premalignant lesions. During this project, I learned numerous molecular biology techniques and inherently developed a strong penchant to pursue a research career in the oral cancer field. After qualifying through a competitive nationwide exam, I was awarded a prestigious five-year predoctoral fellowship from the CSIR foundation, India. As a CSIR research fellow, I joined ACTREC, a pioneering institute dedicated to cancer research in India. My Ph.D. research in Dr. Maru’s laboratory involved studying the chemopreventive role of dietary curcumin in regulating phase I/II enzymes in vivo via AhR and Nrf2 transcription factors. Moreover, I demonstrated that curcumin regulates phorbol ester-induced biochemical and molecular alterations in murine skin via protein kinase C. With the notion of identifying potential clinical biomarkers and to continue my research interest, I studied the effect of dietary turmeric at different stages of oral carcinogenesis in an experimental animal model. I observed that dietary turmeric modulates DMBAinduced p21, MAPKinases and transcription factors (AP-1 and NF-kB) to alter cellular responses related to inflammation, proliferation and apoptosis. In Dr. Maru’s lab, I acquired significant expertise in molecular carcinogenesis and chemoprevention and became highly proficient in the use of in vivo models, including DMBA-induced hamster buccal pouch model of oral cancer. My time in his lab was very productive, with my thesis work culminating with six publications, (four as first author: Garg et al. Carcinogenesis 2008; Garg et al. Carcinogenesis 2008b; Garg et al. Toxicol Appl Pharmacol 2008 and Garg et al. JEPTO 2009), a book chapter, and a review article. I am proud that my work led to several prizes and awards at national/international conferences. I then intended to extend my research to a challenging area: to explore the signaling networks underlying carcinogenesis with the purpose of providing a molecular basis for drug design. Therefore, I moved to the US to join Dr. Marcelo Kazanietz’s Laboratory at the University of Pennsylvania, as a postdoctoral fellow. Dr. Kazanietz is one of the prominent researchers in the field of PKC signaling and cancer. Initially, I started with an ongoing project in the laboratory wherein we observed that transgenic overexpression of PKCe in the mouse prostate induces preneoplastic lesions, and I was the co-author of a 2011 Cell Cycle paper reporting the results of the work. Our study was highlighted in the News and Views Section of Cell Cycle. Dr. Kazanietz then allowed me to design my own project in which I combined my doctoral expertise with the knowledge of PKC biology acquired in his laboratory and successfully demonstrated, through a mechanistic study, that PKCe facilitates the assembly of TNFR-I complex to regulate the NF-kB pathway in prostate cancer (Garg et al., JBC 2012). My thorough bioinformatics analysis to dissect the transcriptional networks controlled by PKC isozymes recently resulted in another first-authored publication (Garg et al, PLoS One 2013). Besides, I encapsulated our current understanding of PKCs in a recently published review article (Garg et al, Oncogene, 2013). I am currently working on two projects that are close to submission to major journals. In the first, by means of cellular and transgenic mice models, I demonstrated that COX-2, a well-known NF-kB regulated gene, acts as a potential mediator of PKCe oncogenesis in prostate cancer, a study that has been supported by a postdoctoral fellowship from the United States Department of Defense. As the PI of this DOD-sponsored grant, I gained experience in cellular, genetic, pharmacological and bioinformatics approaches to delineate signaling pathways that contribute to malignant transformation and developed skills working with xenograft and transgenic mice models. In the second, I identified cooperativity between PKCe and Pten loss for prostate cancer progression.

 Biography
Research Interest :

My research experiences have launched a long-term interest in understanding the indepth mechanisms underlying carcinogenesis, with the ultimate goal of identifying targets for drug-based therapies and developing strategies for overcoming treatment-related resistance observed in most prevalent cancer including prostate, lung and oral squamous cell carcinoma. As is evident from my educational background and trainings, my research experience spans over 10 years in the field of molecular carcinogenesis, cancer chemoprevention, cancer signaling and biochemistry. During undergraduate studies, I worked closely with oral cancer patients and detected and typed the HPV prevalence in the clinical samples. A short but an inspiring experience had made my career goal clearer and allowed me to stay focused in cancer biology field thus far. Moving ahead with my research interest, my doctoral work specifically focused on delineating the mechanism of turmeric/curcumin mediated chemoprevention in vivo model systems (liver, lung, skin and oral tissues of mice and hamsters) and to identify surrogate end point biomarkers for drug effect measurements. During my Ph.D. research, I thus gained thorough experience in working with in vivo cancer models, broadly targeting the carcinogenic process by employing chemopreventive compounds. To extensively explore the essential mechanisms in cancer development and to enhance my acquired skills in the cancer biology field, I joined the renowned signal transduction laboratory of Dr. Kazanietz at UPenn, with the main interest in protein kinase C (PKC). I have focused my postdoctoral studies largely on PKCe, a kinase that is upregulated in many epithelial cancers. Of note, the mechanism by which this kinase contributes to the initiation and maintenance of the prostate cancer phenotype is largely unknown and remains uninvestigated thus far. Using cellular, biochemical, and molecular profiling approaches, I characterized the signaling markers and molecular signature of the prostate lesions driven by PKC epsilon overexpression and Pten loss. I generated organ-specific models for transgenic expression of PKC isozymes and determined the phenotypical consequences of crossing these mice with other models harboring oncogenic alterations such as Pten and K-Ras relevant to prostate, oral and lung cancer. Furthermore, by intercrossing lung-specific mutant Ras mice (LSL-K-rasG12D) with PKCe KO mice, I demonstrated that deletion of the PKCe gene (PRKCE) in mice impaired Ras-mediated lung tumorigenesis. Using human prostate cancer clinical samples, my study established correlation of oncogenic PKC epsilon overexpression with other common alterations (Pten loss, NF-kB hyperactivation, COX-2 and CXCl13 up-regulation) in prostate cancer.

• Experienced in mammalian tissue culture, microarray and bioinformatics analysis, mouse biology, xenograft and transgenic mouse models.
• Excellent communication and organizational skills. Strong interpersonal skills. Ability to work independently and in matrix settings. • Skilled in scientific writings, grant applications and oral presentations
• Leadership/management and organizational role.

Specialties: Cancer biology, signal transduction, short and long term carcinogenesis study, tumor metastasis study, chemoprevention, transcriptional network analysis, microarray and bioinformatics analysis, drug target discovery, protein-protein interaction, DNA-protein interaction, in vivo and in vitro biology, establishing primary cell cultures from mouse prostate and lung tissues, migration, invasion, proliferation assays, gene silencing, generation of recombinant viruses and cell lines, analysis of scientific data, writing and editing.

 Research Interest
 Network
Arun Dharmarajan

Arun Dharmarajan
Professor
Curtin Health Innovation Research Institute (CHIRI)
Curtin University
USA
Tel. +61 8 9266 9867
Fax +61 8 9266 2342

Biography :

Professor Arun Dharmarajan obtained his PhD from the School of Anatomy, Physiology and Human Biology (then Department of Anatomy and Human Biology), University of Western Australia and carried out his postdoctoral position followed by faculty positions at The Johns Hopkins School of Medicine, Baltimore, USA. He spent the last 20 years in the School of Anatomy, Physiology and Human Biology and is currently professor at the School of Biomedical Sciences, Curtin University. He is currently on the National Scientific Committee for the 50th EMBO workshop on Wnt Signalling to be held in Broome, Western Australia from October 6-October 9. He has published over 125 papers and supervised several PhD and M.Sc and Hons students. He is on the editorial boards of several international journals and reviews papers for more than 50 journals.

 Biography
Research Interest :

1) Wnt signalling in particular a Wnt antagonist, Secreted Frizzled Related Protein-4 (sFRP4) and its role in apoptosis and cancer biology 2) Cancer Stem cells 3) Cancer Cell and Cancer Stem Cell Metabolism, 4) Epgenetics 5) Nanotechnology 6) Mesencymal Stem Cells (MSC) and cross talk between MSC and tumour cells.

 Research Interest
 Network
Yoichiro Yoshida

Yoichiro Yoshida, PhD
Gastroenterological Surgery
Fukuoka University
Japan
Tel. 819-280-110-11
Fax 819-286-397-59

Biography :

Yoichiro Yoshida is an Assistant professor in the Department of Gastroenterological Surgery at Fukuoka University, School of Medicine. He was born 1970 in Japan, graduated from University of Occupational & Environmental Health, School of Medicine (1990-1996). In 2000, matriculated at Department of Molecular Biology, School of Medicine, University of Occupational & Environmental Health and did research for drug resistance of anti-cancer agents under the supervision of Kimitoshi Kohno and awarded the PhD in 2004.

 Biography
Research Interest :

Oncology, Cancer chemotherapy, Colorectal cancer and Colorectal surgery.

 Research Interest
 Network
Christian Rolfo

Christian Rolfo, MD, PhD
Department of Oncology
Phase I- Early Clinical Trials Unit
University Hospital Antwerp
Belgium
Tel. +32 3 821 3646

Biography :

Christian Rolfo is part of the working group of the ETOP mesothelioma (European Platform Thoracic Oncology), led by Prof. Rolf Stahel. He is a member of Translational Oncology Multidisciplinary group of university research Institute of Health Sciences (IUNICS) at the University of the Balearic Islands He is member of prestigious Societies Including IASLC, ESMO and ASCO. He was appointed in February 2011 visiting professor in Medical Oncology by the Molecular and Clinical Genetic Oncology Unit at the Interdepartmental Center of Research in Clinical Oncology, School of Medicine, University of Palermo (Italy). In addition to teaching duties at the University of the Balearic Islands.

From October 2012 is Senior Staff Member in the Department of Oncology, University Hospital Antwerp, Belgium, headed by Prof. Marc Peeters. Dr. Rolfo works in Phase I - Early Clinical Trials Unit and Development of new drugs, as well as clinical research projects in thoracic tumors and teaching duties at the University of Antwerp. In November 2012 Dr. Rolfo was distinguished with the title of Senior Fellowship of New Westminster College in Vancouver, British Columbia, Canada.

 Biography
Research Interest :

Lung cancer and clinical practice.

 Research Interest
 Network
Janaina Fernandes

Janaina Fernandes, PhD
Institute of Biophysics
Federal University of Rio de Janeiro
Brazil
Tel. 552-125-626-564

Biography :

Janaina Fernandes is an Adjunct Professor of the Institute of Biophysics at Federal University of Rio de Janeiro. She has received a Ph.D in Biophysics from the Institute Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro. 2001-2005. Received the Carlos Chagas Filho Awards (2008). She is serving as reviewer for the Lung Journal (New York) and as reviewer for research grant application for the Brazilian Health System, Brazilian Health Ministery, and as Editorial board Member for the Journal of Bioequivalence & Bioavailability and Journal of Bioanalysis & Biomedicine. She is author and co-author of international patents and articles on medicinal chemistry, mostly in natural products research.

 Biography
Research Interest :

Discovery of new anti-tumoral agents from Brazilian medicinal plants, development of anti-MDR drugs and identification of intracellular targets and studies of anti-metastatic effects in vivo.

 Research Interest
 Network
Sandip Kumar Mishra

Sandip Kumar Mishra, PhD
Institute of Life Sciences
Nalco Square
India
Tel. 0674-2300702
Fax 0674-2300728

Biography :

Sandip Kumar Mishra is a Scientist-D, Institute of Life Sciences (Govt. of India), Nalco Square, Bhubaneswar-751023, Orissa, India (Since September 2007---continuing) and worked as an Instructor in the Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX-77030, USA, (From 2004-2007). He is an Associate Editor of World Journal of Cancer Research by American Scientific Publishers.

 Biography
Research Interest :

Cancer Biology, Molecular Biology, Chromatin Study.

 Research Interest
 Network
Kaiser Jamil

Kaiser Jamil
Dean and Professor
Centre of Biotechnology and Bioinformatics
Jawaharlal Nehru Institute of Advanced Studies
India
Tel. 91-9676872626

Biography :

Dr. Mrs. Kaiser Jamil, is a distinguished Scientist, having worked in 4 renowned Institutions like IICT, CCMB (both premier Institutes of CSIR), University of Sydney (Australia) and at University of Paris (France). During her career as an active researcher, head of Biology and Biotechnology division of IICT, she established multidisciplinary research in biology and expanded into newer areas of R&D. She has guided 25 PhD students and 80-100, M.Sc /B.Tec; /M.Tech/ and graduate students for project work, 5 students are still working under her supervision for PhD degree. She has published more than 200 papers in peer reviewed journals of repute. Her Career: She graduated from Osmania University (Women’s College), and Masters (M.Sc) from Osmania University (Biology); and joined Indian Institute of Chemical Technology (CSIR Lab) as a research fellow (1965)- completing her PhD in 1971, and joined CCMB (1971), working on Ultra structure and Biochemistry of mammalian reproduction, later in 1982 she moved to IICT as Head of Biology and biotechnology division and handled International Projects from TNO (Netherlands) and Commonwealth Science Council (UK), and went on to establish a Regulatory Toxicology Lab and set up an Electron Microscopy lab. After her superannuation from IICT; she was awarded Emeritus Scientist by CSIR-(till 2005), continued her research, at Genetics Department, Mahavir Hospital and Research Center, as HOD. She established the Cytogenetics and genetic toxicology lab, and completed 3 projects from CSIR, DBT and Inhouse. She then became Research Director of Indo-American Cancer Research Institute (2006-2008) and established a Cancer Biology Lab and Stem Cells lab, and continued her work in Cancer biology. Presently she is engaged in Cancer Biology Projects with an aim to discover Cancer Biomarkers. She has patented her work on Cancer Prognosis- ‘Possible Outcomes in Multi-Factored Diseases’ US patent (2104/CHE/2009), besides several other patents from IICT. She is presently (from 2009- till date), Dean and Honorary Professor for the Centre of Biotechnology and Bioinformatics at Jawaharlal Nehru Institute of Advanced Studies (JNIAS) Hyderabad and has established Biotechnology, Molecular Biology and Bioinformatics Centre at JNIAS, besides her additional charge at Mahavir Hospital and Research Centre, as HOD genetics department. Awards and Honors: she is a life member and Fellow of several Academies, Scientific Associations in which she is holding executive positions, She was one of the top 20 Scientists of the country to be honored with the Award of “Modern Medicare” for her work in cancer research in the area of Pharmacogenomics. She has been a Task force member in committee’s at the Department of Biotechnology (DBT)- Govt of India, and DNES, New Delhi and Advisor at Union Public Service Commission (UPSC)- Govt. of India- New Delhi Recently she was honored with the Lupin Visiting Fellowship Award by ICT- Mumbai- Jan2011, and received Distinguished Scientist Award from Pentagram Research Centre in Feb 2012 and was honored as FELLOW of EMSI in July2012. She is the first woman from India to be elected as President of Third World Organization of Women In Science- OWSD- (TWOWS) with it head quarters in Trieste- Italy which she served from 2005-2010, with a National Chapter of TWOWS for Indian women. She is on the Editorial board of 3 prestigious journals and Reviewer of several journals. Her Passion: “Human dimensions: A vision for Sharing, Learning and Transforming”.

 Biography
Research Interest :

Pharmacogenomics, Genetic toxicology, Cytogenetics, Bioinformatics

 Research Interest
 Network
Khandelwal Sharad Ratan

Khandelwal Sharad Ratan
Associate Professor
Institute of life sciences
Department of Microbiology
HPT/RYK College , Nashik
India
Tel. 0253/2572153(O),0253-2577273(R)
Mob: 91-9881121023
Read Interview session with Khandelwal Sharad Ratan

Biography :
 Biography
Research Interest :

Siderophores (Bacterial)
Agro-biotechnology
Protein chemistry

 Research Interest
 Network
Dona Sinha

Dona Sinha
Department of Receptor Biology & Tumor Metastasis
Chittaranjan National Cancer Institute
India
Tel. +91 3324765101/02/22 extn 327(O)

Biography :

Dr Dona Sinha had received her Ph.D from Chittaranjan National Cancer Institute, Kolkata affiliated under Jadavpur University, Kolkata, India during the year 2007. Currently, she is working as Senior Scientific Officer at Chittaranjan National Cancer Institute, Kolkata, India. She has served as reviewer of several reputed journals including Molecular Nutrition and Food Research, Anti-Cancer Drugs, Journal of Nutritional Biochemistry etc. She has authored 24 research articles/books and has contributed papers in over 30 national and international scientific meetings. She is an active member of American Association of Cancer Research and life member of Indian Science Congress Association and All India Congress on Cytology and Genetics.

 Biography
Research Interest :

• Mitigation of arsenic toxicity
• Cancer chemoprevention with phytochemicals
• Targeting Nrf2 and implication in cancer therapeutics
• Nrf2 mediated redox signaling in cancer chemoprevention
• Identification of MMPs as molecular markers for early detection of cancer
• Regulation and signaling associated with MMPs

 Research Interest
 Network
Noomene Rabii

Noomene Rabii
Associate Professor
Department of visceral surgery
University Tunis El Manar
Tunisia
Tel. +21697465898
Fax +21671135000

Biography :

Dr Rabii Noomene obtained his Medical degree from the faculty of medicine, Tunis Tunisia, in 2002. He fulfilled his national medical services as a hospital medical practitioner. He completed his training in general and gastro-intestinal surgery at the Rabta hospital. He is currently a senior surgeon working in the Habib Thameur hospital Tunis Tunisia. He is an associate professor of surgery and anatomy teaching in the faculty of medicine and the health science high school Tunis Tunisia. He has authored over then 20 journal peer-reviewed publications. He is a regular reviewer and Editorial Board member in several journals

 Biography
Research Interest :

Research interest is gastric and colorectal malignancies

 Research Interest
 Network
Melike Demir Dogan

Melike Demir Dogan
Assistant Professor
Department of Nursing
Gümüşhane University
Turkey

Biography :

Melike Demir Dogan has been graduated from Trakya University, health scholl in 2005. She has been appointed as an Asistant Professor in 2014 in Nursing Depertmant at Gümüşhane University. Her main research interests are symptom management in oncology, Complementary and alternative Manegement, energy approaches of Complementary and alternative Manegement, Geriatric Nursing, radiotherapy nursing

 Biography
Research Interest :

symptom management in oncology, Complementary and alternative Manegement, energy approaches of Complementary and alternative Manegement, Geriatric Nursing, radiotherapy nursing

 Research Interest
 Network
Chandi C. Mandal

Chandi C. Mandal
Assistant Professor
Department of Biochemistry
Central University of Rajasthan
India
Tel. 09650569396

Biography :

Bibliography: Dr. Chandi C Mandal: MSc, Calcutta University, India; PhD, Indian Institute of Technology at Kharagpur, India; Postdoctoral Fellowship, University of Texas Health Science Center at San Antonio, Texas, USA. Dr. Mandal’s research interest is aimed at understanding the cellular signal transduction mechanisms involved in breast cancer, bone metastasis, and bone remodelling. His success is not only reflected in the publications of his research work, but he has won the prestigious Young Investigator Award from ASBMR, multiple travel awards for oral presentations at various international conferences and the Postdoctoral Fellowship Award from CPRIT, USA. His research work has also been highlighted multiple times in Newspaper and reported in Television channels. He is a member of several professional societies such as IACR, ASBMR.

 Biography
Research Interest :

Basic understanding of cellular signal transductions associated with breast cancer, bone metastasis, and bone remodelling.

 Research Interest
 Network
Constantinos Giaginis

Constantinos Giaginis
Department of Food Science and Nutrition
University of the Aegean
Greece
Tel. (0030) 22540-83117

Biography :

Constantinos Giaginis was born in Athens, Greece, in 1979. He received a Chemistry degree from the Department of Chemistry, University of Athens, M.S. and Ph.D. degrees from the Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, and a second Ph.D. degree from the Medical School, University of Athens. He is an Assistant Professor in the field of Human Physiology in the Department of Food Science and Nutrition, University of the Aegean, Greece. His research focuses on the fields of human physiology and pathophysiology, medicinal chemistry and toxicology. His research focuses on the clinical evaluation of new biomarkers and molecular mediators in several pathophysiological disease states, such as diabetes, atherosclerosis, and cancer. His research interest also includes the development of quantitative structure-activity relationships (QSARs) and quantitative structure-property relationships (QSPRs) in the area of pharmacology and toxicology. Furthermore, his research interest lies in the assessment of physicochemical properties, such as lipophilicity, solubility, and ionization of drugs, natural bioactive compounds and toxic compounds in relation with their biological activity or toxicity, as well as their Absorption/Distribution/Metabolism/Excretion (ADME) parameters and their pharmacokinetic and toxicokinetic profile. He has currently published ~100 peer reviewed journal and conference papers.

 Biography
Research Interest :

• Evaluation and clinical significance of biological markers, molecular mediators and receptors implicated in pathophysiological states and especially in cancer and atherosclerosis. • Nuclear receptors and human metabolism and disease. • Physiology and pathophysiology of adipose tissue. • Nutrition and cancer. • Quantitative Structure-Activity/Property Relationships (QSAR/QSPR): investigation of the biological activity and/or toxicity of drugs, xenobiotics and bioactive food ingredients. • Physicochemical properties, absorption and bioavailability of drugs, toxic compounds and bioactive food ingredients.

 Research Interest
 Network
Carlos-Manuel Ortiz-Mendoza

Carlos-Manuel Ortiz-Mendoza
Department of Surgery
National Autonomous University of Mexico
Mexico

Biography :

Carlos-Manuel Ortiz-Mendoza is a Surgical Oncologist: Hospital General “Tacuba”, Social Security and Services Institute for State Workers (ISSSTE: Instituto de Seguridad y Servicios Sociales para los Trabajadores del Estado) from 2001 onwards. Even got various professional experience from many years like 1988 - 1989 Research: Muscle Laboratory, Physiology Department, School of Medicine, UNAM. 1993 - 1994 Research: Muscle Laboratory, Physiology Department, School of Medicine, UNAM. 2000 - 2001 General Surgeon; Mexican Red Cross.Presently he is a Professor, Department of Surgery: School of Medicine, UNAM since 2005. Act as an Editorial Board Member: International Journal of Gynecological and Obstetrical Research, Journal of Clinical Case Reports. Reviewer for Journal of Molecular and Genetic Medicine, Future Oncology etc. Few peer review journal articles. Peer-Review Journal Articles. 1: Paredes-Carbajal MC, Juárez-Oropeza MA, Ortiz-Mendoza CM, Mascher D. Effects of acute and chronic estrogenic treatment on vasomotor responses of aortic rings from ovariectomized rats. Life Sci 1995; 57(5):473-86. ISSN 0024 3205 2: Ortiz-Mendoza CM, Gallo RM, Murguía CAJ. Cecal diverticulitis: report of two patients. Cir Gen 1997; 19(2):142-4. ISSN 1405 0099 3: Ortiz-Mendoza CM, Etchegaray DA, Vivanco RA, Vargas PM, Chapa AO, Gallo RM. Giant hepatic sclerosed hemangioma: patient report. Cir Gen 1998;20(2):139-42. ISSN 1405 0099 4: Ortiz-Mendoza CM, Soto-Villagrán R, Cuellar-Velázquez M. Post-traumatic intrahepatic extraductal bile collection. Rev Gastroenterol Mex. 1998;63(3):159-62. ISSN 0375 0906 5: Barrera-FJL, Ortiz-Mendoza CM, Granados GM. Immunotherapy for recurring squamous-cell carcinoma of the tongue arising in dystrophic epidermolysis bullosa: A case report. Rev Inst Nal Cancerol (Mex) 2000;46(3):183-5. ISSN 0534 3828

 Biography
Research Interest :

General Surgery: Biliary Tract/injuries, Esophageal Neoplasms/diagnosis, Esophageal Stenosis/diagnosis, Liver/injuries, Multiple Trauma/complications, Multiple Trauma/surgery, NeckInjuries/surgery, Surgical Flaps, Wounds, Gunshot/surgery, Vascular Surgery, Gastric Cancer, Endothelial Function, Emergency Management, Abdominal Surgery, Vascular Medicine, Kidney Cancer, Kidney Disease, Trauma Surgery, Vascular Biology, Reconstructive Surgery, Acute Disease, Appendectomy, Appendix, Vascular Endothelium, Sarcoma, Stomach Neoplasms, Digestive System Surgical Procedures, Gastric Surgery, Gastrointestinal Cancer, Endothelial Nitric Oxide Synthase, Cancer, Cancer Research, Cancer Surgery, Oncology. Mammary gland: Breast, Breast Cancer/surgery, Breast Diseases/drug therapy, Breast Neoplasms/epidemiology, Danazol/administration and dosage, Mammography, Mastalgia, Mastectomy/adverse effects, Mexico/epidemiology, Neoplasms/diagnosis, Risk factors, Seroma/epidemiology, Seroma/etiology, Tamoxifen/therapeutic use, Cancer Epidemiology, Breast Cancer Screening, Breast Cancer, Cancer, Cancer Research, Breast Cancer Management, Breast Biology, Breast Imaging, Cancer Surgery, Oncology, Obesity/epidemiology, Obesity/Mexico, Metabolic Syndrome X/diagnosis, Metabolic Syndrome X/ epidemiology. Gynecology oncology: Cancer/Mexico, Carcinoma Endometrioid/epidemiology, Diabetes Mellitus/Mexico, Endometrial Neoplasms/epidemiology, Hysterectomy, Lymph Node Excision, Neoplasms, Obesity/epidemiology, Obesity/Mexico, Pelvis, Uterine Cervical Neoplasms/pathology, Uterine Cervical Neoplasms/prevention & control, Uterine Cervical Neoplasms/surgery, Uterus/surgery, Cancer Epidemiology, Cervical Cancer, Endometrial Cancer, Cervical Cancer Prevention, Uterine Cervical Neoplasms, Lymph Nodes, Pelvic Neoplasms, Endometrial Neoplasms, Cancer, Cancer Research, Cancer Surgery, Oncology, Fibroma/pathology, Ovarian neoplasms/pathology, Castleman’s disease, Ovarian Cancer, Postmenopausal. Skin cancer: Epidemolysis Bullosa Dystrophica/complications, Skin Neoplasms/diagnosis, Skin Neoplasms/surgery, Skin Cancer, Skin Neoplasms, Cancer Surgery, Oncology.

 Research Interest
 Network
 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version